
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Novel Benzofuran-3-yl-methyl and Aliphatic Azacyclics: Design, Synthesis, and In Vitro and In Silico anti-Alzheimer Disease Activity Studies - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7131F89B72E431C131F00258546E6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsomega">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Omega">
<meta name="citation_title" content="Novel Benzofuran-3-yl-methyl and Aliphatic Azacyclics: Design, Synthesis, and In Vitro and In Silico anti-Alzheimer Disease Activity Studies">
<meta name="citation_author" content="Büşra Gebeş-Alperen">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey">
<meta name="citation_author" content="Asaf Evrim Evren">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey">
<meta name="citation_author" content="Begüm Nurpelin Sağlik Özkan">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey">
<meta name="citation_author" content="Ahmet Cagri Karaburun">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey">
<meta name="citation_author" content="Nalan Gundogdu-Karaburun">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey">
<meta name="citation_publication_date" content="2025 Jul 22">
<meta name="citation_volume" content="10">
<meta name="citation_issue" content="30">
<meta name="citation_firstpage" content="32829">
<meta name="citation_doi" content="10.1021/acsomega.5c01432">
<meta name="citation_pmid" content="40787376">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/pdf/ao5c01432.pdf">
<meta name="description" content="Neurological disorders represent a significant burden on human health, particularly as global life expectancy continues to rise. Among these conditions, Alzheimer’s disease is notably prevalent. Of greater concern, if left untreated or unaddressed, ...">
<meta name="og:title" content="Novel Benzofuran-3-yl-methyl and Aliphatic Azacyclics: Design, Synthesis, and In Vitro and In Silico anti-Alzheimer Disease Activity Studies">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Neurological disorders represent a significant burden on human health, particularly as global life expectancy continues to rise. Among these conditions, Alzheimer’s disease is notably prevalent. Of greater concern, if left untreated or unaddressed, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332554">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsomega.5c01432"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ao5c01432.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332554%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332554/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332554/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsomega.png" alt="ACS Omega logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Omega" title="Link to ACS Omega" shape="default" href="https://pubs.acs.org/journal/acsodf" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Omega</button></div>. 2025 Jul 22;10(30):32829–32843. doi: <a href="https://doi.org/10.1021/acsomega.5c01432" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsomega.5c01432</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Omega%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Omega%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Novel Benzofuran-3-yl-methyl
and Aliphatic Azacyclics:
Design, Synthesis, and In Vitro and In Silico anti-Alzheimer Disease
Activity Studies</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gebe%C5%9F-Alperen%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Büşra Gebeş-Alperen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Büşra Gebeş-Alperen</span></h3>
<div class="p">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gebe%C5%9F-Alperen%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Büşra Gebeş-Alperen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evren%20AE%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Asaf Evrim Evren</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Asaf Evrim Evren</span></h3>
<div class="p">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evren%20AE%22%5BAuthor%5D" class="usa-link"><span class="name western">Asaf Evrim Evren</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sa%C4%9Flik%20%C3%96zkan%20BN%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Begüm Nurpelin Sağlik Özkan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Begüm Nurpelin Sağlik Özkan</span></h3>
<div class="p">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sa%C4%9Flik%20%C3%96zkan%20BN%22%5BAuthor%5D" class="usa-link"><span class="name western">Begüm Nurpelin Sağlik Özkan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karaburun%20AC%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ahmet Cagri Karaburun</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ahmet Cagri Karaburun</span></h3>
<div class="p">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karaburun%20AC%22%5BAuthor%5D" class="usa-link"><span class="name western">Ahmet Cagri Karaburun</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gundogdu-Karaburun%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Nalan Gundogdu-Karaburun</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Nalan Gundogdu-Karaburun</span></h3>
<div class="p">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gundogdu-Karaburun%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nalan Gundogdu-Karaburun</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Faculty of Pharmacy, Department
of Pharmaceutical Chemistry, Anadolu University, 26470
Eskişehir, Turkey
</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">
Email: <span>asafevrimevren@anadolu.edu.tr</span>.</p>
</div>
<div class="fn" id="cor2">
<sup>*</sup><p class="display-inline">
Email: <span>ngundogd@anadolu.edu.tr</span>.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 15; Accepted 2025 Jul 11; Revised 2025 Jul 8; Collection date 2025 Aug 5.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332554  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40787376/" class="usa-link">40787376</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Neurological disorders represent a significant burden
on human
health, particularly as global life expectancy continues to rise.
Among these conditions, Alzheimer’s disease is notably prevalent.
Of greater concern, if left untreated or unaddressed, Alzheimer’s
disease can progress to dementia, leading to severe cognitive decline
and a substantial reduction in quality of life. In this study, 15
novel benzofuran-azacyclic hybrids were designed and synthesized.
The final compounds were evaluated for their inhibitory potency on
AChE and BACE-1 enzymes, and in silico studies were performed to clarify
their binding modes. Finally, structure–activity relationships
(SARs) were proposed for future studies. The results indicated that
the most promising compound is <strong>4m</strong>, which contains <em>N</em>-(2-hydroxyethyl)­piperazine and benzofuran moieties. These
moieties effectively occupied the substrate channel of the AChE enzyme
and the catalytic cleft of the BACE-1 enzyme. Additionally, compounds <strong>4e</strong> (benzyl piperidine) and <strong>4h</strong> (2-furoyl piperazine)
showed dual inhibitory activity on both enzymes. In conclusion, the
tubular form with a stopper group shows great potential for the treatment
of Alzheimer’s disease, as it blocks the entrance cavity of
the AChE active pocket for the substrate and increases the stability
of the inactive BACE-1 enzyme. Moreover, electrolytes, specifically
sodium ions in this case, play a crucial role in stabilizing the <strong>4m</strong>-BACE-1 protein complex. For further studies, we suggest
that the tubular form with a stopper can serve as a potential pharmacophore
and an appropriate starting point for drug development.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/672bed2fb5ff/ao5c01432_0013.jpg" loading="lazy" id="abs1" height="372" width="564" alt="graphic file with name ao5c01432_0013.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/672bed2fb5ff/ao5c01432_0011.jpg" loading="lazy" id="tgr1" height="372" width="564" alt="graphic file with name ao5c01432_0011.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Developments in technology
and innovations in health sciences have
significantly contributed to the extension of average human life.
The recorded life expectancy at birth increased from 44 years in Sweden
in 1840 to 82 years in Japan in 2005. As
life expectancy has increased, age-related health issues have become
more prominent and are now major global concerns. These include cancer
and neurological disorders. Unfortunately, treatment options are mostly
palliative and cannot cure these diseases or eliminate their underlying
causes. Therefore, if a patient is not
diagnosed in the early stages of the disease, the available treatment
options are limited or even ineffective. To address this issue, researchers
have aimed to develop dual inhibitors targeting both AChE and β-secretase.<em>
−

</em> This approach holds promise for treating patients at both early
and late stages of disease.</p>
<p>Based on this background, in this
study we focused on benzofuran–piperazine
analogs to fight against Alzheimer’s Disease. The benzofuran
ring system has been investigated for the treatment of various diseases
such as cancer,<em>
−

</em> diabetes, soreness, anxiety, depression, Parkinson disease and also various infections.<em>
,
</em> As known, benzofuran
was chosen as a bioisosteric alternative to the indanone ring present
in donepezil and galantamine, with the aim of exploring structural
diversity while retaining interaction potential with the cholinesterase
active site. This makes it an attractive scaffold for researchers
developing anti-Alzheimer’s disease agents. Because of this
bioisosterism, benzofuran derivatives have been explored for their
potential to inhibit AChE<em>
,
</em> and BACE-1<em>
,
</em> enzymes or both of them at the same time,<em>
,
</em> as same as moracin analogs. These studies
suggest that the benzofuran ring is a valuable pharmacophore worth
investigating for dual activity against both AChE and BACE-1.</p>
<p>Furthermore, aliphatic azacyclic structures such as piperidine,
morpholine, and piperazine rings also exhibit anticancer,<em>
,
</em> antidiabetic,<em>
,
</em> analgesic,<em>
,
</em> anxiolytic and antidepressant.<em>
,
</em> These ring
systems are commonly found in neurological drugs, as illustrated in <a href="#sch1" class="usa-link">Scheme 
</a>. Additionally, piperidine,
piperazine, and morpholine derivatives have been reported to show
dual inhibitory activity on AChE and BACE-1 enzymes.<em>
−








</em>
</p>
<figure class="fig xbox font-sm" id="sch1"><h3 class="obj_head">1. Drugs Used Clinically Including Aliphatic Azacyclic Moieties, and
Donepezil and Galantamine
.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/b3622f9f2011/ao5c01432_0007.jpg" loading="lazy" id="gr1" height="707" width="772" alt="1"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="s1fn1"><sup>a</sup> Azacyclic zstructures
are represented
by red, benzofuran moiety is represented by green.</p></figcaption></figure><p>In light of the above information, to explore structural diversity
while retaining interaction potential with the enzyme active sites,
15 novel benzofuran and aliphatic azacyclic hybrids were synthesized
by linking them through a dithiocarbamate moiety. The structures of
the final compounds were confirmed using HRMS, as well as <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy. Their anti-Alzheimer potential
was evaluated against AChE, BuChE, and BACE-1 enzymes through both
in vitro and in silico studies. Although the primary aim was to investigate
the anti-Alzheimer disease activity of the newly designed benzofuran–azacyclic
hybrids, we were also interested in examining the inhibitory effect
of the tubular form modified with a “stopper” (The benzoyl
moiety of the final compounds is positioned at the entrance of the
enzyme’s active site, where it acts as a steric barrier, similar
to how a wine stopper seals a bottle). This novel configuration may
offer an alternative to conventional tubular drugs, with the added
stopper potentially enhancing pharmacological performance. Additionally,
structure–activity relationships (SARs) were discussed to clarify
the impact of structural features on biological activity.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Results and Discussion</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">2.1. Chemistry</h3>
<p>The synthetic route for
the final compounds is illustrated in <a href="#sch2" class="usa-link">Scheme 
</a>. The process involved three main steps.
First, a ring-closure reaction between 2-bromoacetophenone and 2′-hydroxyacetophenone
was carried out to obtain 2-benzoyl-3-methylbenzofuran (compound 1).
In the second step, compound 1 was brominated using <em>N</em>-bromosuccinimide (NBS) to introduce a bromomethyl group at the 3-position
of the benzofuran ring, yielding compound 2. In the final step, compound
2 was reacted with various dithiocarbamate derivatives under S<sub>N</sub>2 conditions to yield the target compounds.</p>
<figure class="fig xbox font-sm" id="sch2"><h4 class="obj_head">2. General Synthesis
Diagram
.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/0eaeb32ca714/ao5c01432_0008.jpg" loading="lazy" id="gr2" height="748" width="773" alt="2"></a></p>
<div class="p text-right font-secondary"><a href="figure/sch2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="s2fn1"><sup>a</sup> Reaction condition:
(a) K<sub>2</sub>CO<sub>3</sub>/CH<sub>3</sub>CN/reflux; (b) NBS/Benzoyl
peroxide/CCl<sub>4</sub>/reflux; (c) Acetone, rt (<strong>M</strong>:
Na or K).</p></figcaption></figure><p>The synthesized compounds are presented
in <a href="#tbl1" class="usa-link">Table 
</a>. Based on
IR spectral analysis, the aromatic
C–H stretching vibrations appeared in the range of 2904–3089
cm<sup>–1</sup>. The carbonyl (CO) stretching band
of the benzoyl group located at the 2-position of the benzofuran ring
was observed between 1633–1645 cm<sup>–1</sup>. The
CC, CS, and C–O stretching bands were detected
in the ranges of 1552–1597 cm<sup>–1</sup>, 1267–1292
cm<sup>–1</sup>, and 1215–1232 cm<sup>–1</sup>, respectively. Furthermore, characteristic peaks of monosubstituted
benzene rings were observed at 715–758 cm<sup>–1</sup> and 677–709 cm<sup>–1</sup> as two distinct peaks,
while the 1,4-disubstituted benzene ring showed a single peak in the
range of 881–887 cm<sup>–1</sup>.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">1. Core Structure and R Groups.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/c6846b537691/ao5c01432_0009.jpg" loading="lazy" id="gr11" height="599" width="583" alt="2.1."></p>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/25a511e37ccf/ao5c01432_0010.jpg" loading="lazy" id="gr12" height="434" width="776" alt="2.1."></a></p>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>In the <sup>1</sup>H NMR spectra, the methylene protons
(−CH<sub>2</sub>–S−) of the common structure
appeared as a singlet
between 5.05–5.10 ppm. The aliphatic −CH<sub>2</sub>– signals attributed to the piperazine ring were observed
in the range of 4.00–4.30 ppm. Aromatic protons resonated between
6.64–8.39 ppm.</p>
<p>In the <sup>13</sup>C NMR spectra, the
common and consistent carbon
signals of all derivatives were evaluated. The total number of carbon
peaks in each spectrum matched the expected values. For compound <strong>4o</strong>, which contains a fluorine atom as a substituent, additional
splitting was observed. This is attributed to C–F couplings,
which caused splitting of the carbon signals directly bonded to fluorine
as well as those adjacent to it, as previously reported in the literature.
Peaks corresponding to S–CH<sub>2</sub> and CS, which
confirm the ester-like structure of the dithiocarbamate moiety, were
detected in the ranges of 30.42–32.09 ppm and 193.20–195.12
ppm, respectively.</p></section><section id="sec2.2"><h3 class="pmc_sec_title">2.2. Cholinesterase Activities</h3>
<p>Inhibition
% and IC<sub>50</sub> doses of the final compounds and standard drugs
were displayed in <a href="#tbl2" class="usa-link">Tables 
</a> and , respectively.</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">2. % Inhibition of the Synthesized Compounds,
Donepezil and Tacrine against AChE and BChE.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0014.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/e4fbd114f235/ao5c01432_0014.jpg" loading="lazy" id="gr9" height="526" width="787" alt="2.2."></a></p>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">3. IC<sub>50</sub> Values of <strong>4e</strong>, <strong>4h</strong>, <strong>4m</strong> and <strong>4o</strong> and Donepezil
against AChE.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0015.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/824d124d7e07/ao5c01432_0015.jpg" loading="lazy" id="gr10" height="276" width="787" alt="2.2."></a></p>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>According to the preliminary screening tests (at 10<sup>–3</sup> and 10<sup>–4</sup> M concentration) on AChE
and BChE enzymes,
compounds <strong>4e</strong>, <strong>4h</strong>, <strong>4m</strong> and <strong>4o</strong> showed better anti-AChE activity than other synthesized
analogs and similar activity to donepezil, that is why they were evaluated
in various concentrations (10<sup>–3</sup>–10<sup>–9</sup> M) and then calculated their IC<sub>50</sub> values. However, none
of the final compounds showed an inhibition profile better than or
similar to tacrine on BChE.</p>
<p>According to IC<sub>50</sub> doses,
compound <strong>4m</strong> (2-hydroxyethyl)
showed better activity than other three compounds (<strong>4e</strong>, <strong>4h</strong>, and <strong>4o</strong>), but it is not better as
donepezil. The less active compound among them is <strong>4h</strong>,
which has furoyl piperazine moiety.</p>
<p>The findings indicated that
piperidine substituted with bulky groups
exhibited higher activity compared to those with smaller substituents.
In contrast, piperazine derivatives bearing groups capable of forming
hydrogen bonds did not show significant activity on their own. Furthermore,
it appears that such substituents must be positioned at a minimum
of three carbon atoms away from the fourth nitrogen of the piperazine
ring to exhibit activity. Although compound <strong>4g</strong> fits this
structural description, its IC<sub>50</sub> value was measured between
10<sup>–3</sup> and 10<sup>–4</sup> M, which classifies
it as a weak inhibitor. Therefore, additional structural factors must
be considered to better understand the structure–activity relationship
(SAR). We propose that piperazine rings substituted with flexible
groups, such as 2-hydroxyethyl or 3-(<em>N</em>,<em>N</em>-dimethyl)­propyl, may present a more polarized topological surface.
This polarity may contribute to enhanced activity. In this context,
one explanation could be that shorter carbon chains positively influence
the polarization of the molecular surface. For instance, while compound <strong>4m</strong> effectively inhibited AChE at low concentrations, compound <strong>4g</strong> did not, possibly due to its longer chain. Another plausible
explanation is that the five-atom distance in compound <strong>4g</strong> from the azacyclic core prevents optimal positioning within the
enzyme’s active site. Based on these observations, we suggest
that a three- or four-atom distance from the azacyclic moiety is optimal
when the substituents are straight-chain groups. However, if the substituents
are aromatic rings, then a four- or five-atom linker (as observed
in compounds <strong>4e</strong> and <strong>4h</strong>, respectively) results
in higher activity.</p></section><section id="sec2.3"><h3 class="pmc_sec_title">2.3. β-Secretase Activities</h3>
<p>The
compounds showing the highest AChE inhibitory activity, along with
reference drugs, were also evaluated for their effect on the BACE-1
enzyme. The results are presented in <a href="#tbl4" class="usa-link">Table 
</a>. Among all, compound <strong>4m</strong> demonstrated
the highest inhibitory activity against BACE-1 (IC<sub>50</sub>: 0.134
± 0.006 μM), performing better than donepezil (IC<sub>50</sub>: 0.110 ± 0.005 μM), although it was less potent than
verubecestat (IC<sub>50</sub>: 0.031 ± 0.001 μM). Given
that <strong>4m</strong>′s inhibition potency was approximately
twice that of compounds <strong>4e</strong> and <strong>4h</strong>, and compound <strong>4o</strong> showed no significant inhibition, we propose the following:
When the substituents on the azacyclic ring are flexible and small,
the inhibitory activity is enhanced. However, if the substituent lacks
the ability to form hydrogen bonds, a notable decrease in inhibition
efficiency is observed.</p>
<section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">4. IC<sub>50</sub> Values of <strong>4e</strong>, <strong>4h</strong>, <strong>4m</strong> and <strong>4o</strong> and Donepezil
against BACE-1.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">compounds</th>
<th align="center" colspan="1" rowspan="1">β-secretase (BACE-1) IC<sub>50</sub> (μM)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4e</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.134 ± 0.006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4h</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.155 ± 0.007</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4m</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.084 ± 0.003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>4o</strong>
</td>
<td align="left" colspan="1" rowspan="1">&gt;10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>donepezil</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.110 ± 0.005</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>verubecestat</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.031 ± 0.001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec2.4"><h3 class="pmc_sec_title">2.4. Kinetic Studies of AChE Enzyme Inhibition</h3>
<p>Enzyme kinetics studies were conducted to determine the mechanism
of inhibition of AChE using a procedure similar to that of the inhibition
assay for cholinesterase enzymes. These studies were performed with
compound <strong>4m</strong>, which was found to be the most potent agent.
Linear Lineweaver–Burk graphs were used to estimate the type
of inhibition of this compound. The velocity curves of the substrates
were recorded in the absence and presence of compound <strong>4m</strong>. This compound was prepared for enzyme kinetic studies at concentrations
of IC<sub>50</sub>/2, IC<sub>50</sub>, and 2 × IC<sub>50</sub>. In each case, the initial velocity measurements were obtained at
different substrate (ATC) concentrations ranging from 600 to 18.75
μM. To calculate the <em>K</em>
<sub>i</sub> (intercept
on the <em>x</em>-axis) values of this compound value, the
secondary plots of slope (<em>K</em>
<sub>m</sub>/<em>V</em>
<sub>max</sub>) versus varying concentrations (0, IC<sub>50</sub>/2, IC<sub>50</sub>, and 2 × IC<sub>50</sub>) were created.
The graphical analyses of steady-state inhibition data for compound <strong>4m</strong> are shown in <a href="#fig1" class="usa-link">Figure 
</a>.</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/69b41f3082b1/ao5c01432_0001.jpg" loading="lazy" id="gr3" height="734" width="646" alt="1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Lineweaver–Burk plots for the inhibition of AChE by
compound <strong>4m</strong>. [S], substrate concentration (μM); <em>V</em>, reaction velocity (1/<em>V</em> (abs/min)<sup>−1</sup>). Inhibitor concentrations are shown at the left.
(B) Secondary plot for the calculation of the steady-state inhibition
constant (<em>K</em>
<sub>i</sub>) of compound <strong>4m</strong>. <em>K</em>
<sub>i</sub> was calculated as 0.051 μM.</p></figcaption></figure><p>According to the Lineweaver–Burk plots,
the type of inhibition
consists of two general classes: reversible or irreversible. Mixed-type,
uncompetitive, competitive, and noncompetitive inhibition types are
included in the reversible inhibition [1–3]. As seen in the
Lineweaver–Burk plot of compound <strong>4m</strong> (<a href="#fig1" class="usa-link">Figure 
</a>), a graph with lines
that do not intersect at the <em>x</em>-axis or the <em>y</em>-axis was formed. This observation indicated that compound <strong>4m</strong> was a reversible and mixed-type inhibitor with similar
inhibition features as the substrates. Furthermore, the <em>K</em>
<sub>i</sub> value of compound <strong>4m</strong> was calculated as
0.051 μM with the help of a secondary plot.</p>
<section id="sec2.4.1"><h4 class="pmc_sec_title">2.4.1. Molecular Docking Studies on AChE</h4>
<p>To understand binding mode, structure-based docking protocol was
applied. According to docking studies (<a href="#fig2" class="usa-link">Figure 
</a>), the settlement at the inhibitory cavity
of all active compounds was found very similar, thus, 2-benzoylbenzofuran
structure can be marked as a valuable pharmacophore core.</p>
<figure class="fig xbox font-sm" id="fig2"><h5 class="obj_head">2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/4ea4637d163d/ao5c01432_0002.jpg" loading="lazy" id="gr4" height="689" width="697" alt="2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>2D and 3D docking
poses of <strong>4e</strong> (A), <strong>4h</strong> (B), <strong>4m</strong> (C), <strong>4o</strong> (D), and their superimposed
(E) at AChE binding cavity (PDBID: <a href="https://www.rcsb.org/structure/4EY7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">4EY7</a>), respectively.</p></figcaption></figure><p>In fact, all compounds interacted with the Trp86
(catalytic active
site, CAS) and Trp286 (peripheral anionic site, PAS) amino acid residues.
Additionally, all compounds except <strong>4o</strong> formed interactions
with Ser293, a residue located in the ATP-binding pocket. Since compound <strong>4o</strong> is slightly shorter than the other active derivatives,
this provided a useful insight: introducing one or two sp<sup>3</sup>-hybridized carbon atoms between the piperazine and phenyl ringas
seen in compound <strong>4e</strong>could potentially enhance
its inhibitory activity by enabling deeper access into the CAS region.
Indeed, similar to the structure of donepezil, benzyl piperazine (in
this case, we propose 4-fluorobenzyl piperazine) could serve as an
appropriate substituent. Compound <strong>4e</strong>, in fact, was designed
as a structural analog of <strong>4o</strong> to explore this hypothesis.
Although in vitro results indicated that <strong>4o</strong> was more
effective than <strong>4e</strong>, compound <strong>4e</strong> formed more
molecular interactions. Based on this, we suggest that ideal structures
should incorporate benzyl piperazine analogs, such as the 4-fluorobenzyl-substituted
piperazine. The most potent compound, <strong>4m</strong>, bearing a 2-hydroxyethyl
piperazine moiety, was able to interact with key amino acids in the
CAS region, particularly Trp86 (via aromatic hydrogen bonding) and
Tyr133 (through hydrogen bonding). Another noteworthy observation
is that compound <strong>4h</strong> lacks a positively charged nitrogen
atom in its side chain, which likely results in unstable interactions
with the enzyme, especially since this region of the binding pocket
includes residues that can carry charge. To further elucidate the
binding mode and gain deeper insight into the structure–activity
relationship (SAR), molecular dynamics simulations (MDS) were performed
using the compound <strong>4m</strong>AChE complex as a representative
model.</p></section><section id="sec2.4.2"><h4 class="pmc_sec_title">2.4.2. Molecular Docking Studies on BACE-1 Enzyme</h4>
<p>Docking poses of active compounds (<strong>4e</strong>, <strong>4h</strong> and <strong>4m</strong>) on β-secretase enzyme were shared in <a href="#fig3" class="usa-link">Figure 
</a>.</p>
<figure class="fig xbox font-sm" id="fig3"><h5 class="obj_head">3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/2f162eb118fa/ao5c01432_0003.jpg" loading="lazy" id="gr5" height="612" width="697" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Superimposed of the active
compounds from two opposite perspectives
(A), and 2D and 3D docking poses of <strong>4e</strong> (B), <strong>4h</strong> (C), and <strong>4m</strong> (D) at BACE-1 catalytic cleft (PDBID: <a href="https://www.rcsb.org/structure/2ZJM" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">2ZJM</a>), respectively.</p></figcaption></figure><p>Three active compounds were found to fit well within
the catalytic
cleft of the β-secretase enzyme (<a href="#fig3" class="usa-link">Figure 
</a>A). The common structural moiety, 1-benzofuran-2-yl­(phenyl)­methanone
(BPM), interacted with Tyr198 via hydrogen bonding and π–π
stacking, thus occupying the S2′ and S3′ subpockets,
while the phenyl group extended into the S4′ subpocket. The
dithiocarbamate groups of the compounds were positioned between Tyr71
and Asp228 and extended into the S1, S4, and S1′ pockets through
their azacyclic moieties. Variations on this aliphatic ring were directed
toward the S3 and S4 pockets and positioned accordingly. Based on
these observations, we suggest that the nature of the substituents
significantly influences the stabilization of the enzyme–inhibitor
complex, and thereby, the overall biological activity. Specifically,
in these pockets, the 2-hydroxyethyl group of compound <strong>4m</strong> formed direct hydrogen bonds with Gln73 and Lys107, whereas the
furoyl group of compound <strong>4h</strong> interacted with Gly230 and
Thr232 through water-mediated hydrogen bonds. In summary, we concluded
that the BPM scaffold is highly effective, as it engages both the
S2′ and S3′ subpockets and simultaneously interacts
with three distinct loop-region amino acids. To gain deeper insight
into the binding mechanism, molecular dynamics simulations were carried
out using the compound <strong>4m</strong>–β-secretase complex
as a representative model.</p></section><section id="sec2.4.3"><h4 class="pmc_sec_title">2.4.3. Molecular Dynamics Simulation Studies on
AChE</h4>
<p>Stability-related plots are presented in <a href="#fig4" class="usa-link">Figure 
</a>A–C. The average radius
of gyration (<em>R</em>
<sub>g</sub>) was approximately 4.8
Å, with the system reaching equilibrium and displaying minimal
fluctuations after 12.8 ns. Notably, no drastic deviations were observed
before this point, indicating that the system retained structural
integrity throughout the simulation. The root-mean-square deviation
(RMSD) values were as follows: 0.00–1.88 Å for the protein,
0.00–4.79 Å for the ligand aligned to the protein, and
0.00–2.06 Å for the ligand aligned to itself. These results
demonstrate that the protein–ligand complex remained stable
during the simulation period. The root-mean-square fluctuation (RMSF)
values for amino acids in α-helices and β-strands remained
below 0.8 Å, while loop-region residues involved in ligand interactions
exhibited RMSF values below 1.0 Å. These fluctuations are within
acceptable ranges, as supported by several previous studies.<em>
−


</em>
</p>
<figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/a0a5ba8e286e/ao5c01432_0004.jpg" loading="lazy" id="gr6" height="680" width="697" alt="4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MDS
result for the <strong>4m</strong>-AChE complex. (A–C) showed
the complex stability; and (D–F) showed the interaction diagrams
during 100 ns simulation. (A) <strong>4m</strong> properties (RMSD, <em>R</em>
<sub>g</sub>, intraHB, MolSA, SASA, and PSA; (B) RMSD values
(Protein; ligand fit on protein; and ligand fit on ligand); (C) RMSF
diagram; (D) interaction fraction–residue diagram; (E) total
connections-residues-time plot; (F) 2D interaction pose with connection
strength (cut off = 0.2) at the active region).</p></figcaption></figure><p>After assessing the stability of the complex, the
entire simulation
was analyzed to understand the binding mode of the ligand–protein
complex in relation to time and environmental changes. As shown in <a href="#fig4" class="usa-link">Figure 
</a>D,E, the residues
Trp86, Tyr124, Ser203, Trp286, and Tyr341 exhibited the most interactions
compared to other active pocket amino acids. Notably, the interactions
with Trp86 and Tyr341 decreased between 38 and 78 ns, likely due to
weak contacts, as these interactions were primarily hydrophobic in
nature. However, after 78 ns, the interaction frequencies with these
residues increased again. We propose that the ligand’s activity
was predominantly driven by interactions with Trp86, Ser203, and Trp286.
Meanwhile, residues such as Gly120, Gly121, Gly122, Tyr124, Tyr133,
and Glu202 played a crucial role in stabilizing the complex, preventing
the ligand from dissociating from the substrate-binding region, and
thereby ensuring the continued inhibitory effect. This stability was
maintained despite intermittent disruptions in interactions with Trp86
(as observed in video 1, <a href="#fig4" class="usa-link">Figure 
</a>). Notably, the <em>N</em>-(2-hydroxyethyl)­piperazine
moiety of the ligand penetrated the CAS region of the AChE enzyme
pocket, while the 1,1-diaryl methanone moiety occupied the PAS region,
functioning as a stopper. Thus, the 1,1-diaryl methanone group effectively
creates a barrier, preventing the entry of the substrate (acetylcholine)
and water molecules into the active site (see video 1 and <a href="#fig5" class="usa-link">Figure 
</a>).</p>
<figure class="fig xbox font-sm" id="fig5"><h5 class="obj_head">5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/1345411f806b/ao5c01432_0005.jpg" loading="lazy" id="gr7" height="660" width="718" alt="5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative snaps
extracted from MDS of (B) 0.0 ns, (C) 33.3
ns, (D) 66.6 ns, and (E) 100.0 ns. The occlusion of the AChE substrate-binding
channel induced by the presence of compound <strong>4m</strong> (its structure
represented in (A)). Only interacted residues are displayed, and the
red carbon residues represent mentioned as important ones in previous
studies. White surface area (transparency front = 20, and back = 0)
was used for rendering the AChE substrate-binding channels shape.</p></figcaption></figure><p>In conclusion, unlike the classic tubular structure
of AChE inhibitors,
experimental studies have suggested that the combination of a polarizable
straight chain and rigid hydrophobic rings is an effective approach
for AChE inhibition. As detailed in the in silico section, this combination
is attributed to the polarization of the straight chain and the bulky
hydrophobic rings of the compounds. The hydrophobic rings act as a
barrier at the enzyme’s entrance, blocking substrate binding
like wine stopper, while the polarized straight chain interacts with
charged residues, stabilizing the complex. This stabilization is further
supported by the hydrophobic moiety of compound <strong>4m</strong> through
its interaction with Trp286 (as seen in video 1 and <a href="#fig4" class="usa-link">Figure 
</a>C–E). Consequently,
the in silico studies predicted possible binding modes, and these
findings highlight that a group capable of forming hydrogen bonds
can enhance the frequency of interactions in the CAS region. For future
studies, the key points and suggestions outlined here should be considered
when designing and developing new AChE inhibitors.</p></section><section id="sec2.4.4"><h4 class="pmc_sec_title">2.4.4. MDS Studies on BACE-1</h4>
<p>Similar to <strong>4m</strong>-AChE complex, <strong>4m</strong>-BACE-1 complex has a good
stability profile as shown in <a href="#fig6" class="usa-link">Figure 
</a>A–C. The overall rG value was calculated 4.7
Å and it did not show drastic changes during simulation time.
The maximum RMSD value for protein was calculated as 2.29 Å.
Similar to <strong>4m</strong>-AChE complex, the RMSF values of α-helix
and β-strand region amino acids were under 0.8 Å while
the RMSF values of loop region amino acids, if the ligand interacted
with them, were observed under 1.5 Å. For this complex, all values
are acceptable (as mentioned in MDS of AChE) and gesture that the
stability of the <strong>4m</strong>-BACE-1 complex was not interrupted.</p>
<figure class="fig xbox font-sm" id="fig6"><h5 class="obj_head">6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332554_ao5c01432_0006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c8/12332554/208d482b76a1/ao5c01432_0006.jpg" loading="lazy" id="gr8" height="683" width="697" alt="6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MDS result
for the <strong>4m</strong>-BACE-1 complex. (A–C)
showed the complex stability; and (D–F) showed the interaction
diagrams during 100 ns simulation. (A): <strong>4m</strong> properties
(RMSD, <em>R</em>
<sub>g</sub>, intraHB, MolSA, SASA, and PSA;
(B): RMSD values (protein; ligand fit on protein; and ligand fit on
ligand); (C): RMSF diagram; (D) Interaction fraction–residue
diagram; (E) total connections-residues-time plot; (F) 2D interaction
pose with connection strength (cut off = 0.20) at the active region).</p></figcaption></figure><p>The MDS results (<a href="#fig6" class="usa-link">Figure 
</a>D,F and video 2) indicated that the Asp32,
Tyr71, and Gly230
residues play an important role in inhibitory activity. Notably, interactions
with Asp32 and Gly230 exhibited sodium-mediated chelation after 15.90
ns. Following this time, the interactions with Asp32 remained consistent.
Similar to the docking study results, the BPM moiety localized to
the S2′ and S3′ subpockets and intermittently interacted
with three loop regions, with Tyr71 (via π–π stacking)
playing a significant role. The oxygen atom of the benzofuran group
frequently formed aromatic hydrogen bonds with Tyr198, while the benzoyl
group formed aromatic hydrogen bonds with Pro70, Ile126, and Tyr198.
Therefore, we continue to suggest that BPM serves as an effective
pharmacophore structure against β-secretase. On the other hand,
the 2-hydroxyethyl group in compound <strong>4m</strong> occupied the
S3 and S4 pockets by forming either direct or aromatic hydrogen bonds.
We propose that this tail is likely responsible for the indirect inhibitory
activity by enhancing the stability of the complex.</p>
<p>In summary,
our results indicate that the main activity is attributed
to 1-benzofuran-2-yl­(phenyl) methanone (BPM), while the tail plays
an indirect role in modulating inhibitory activity. Additionally,
we observed similar structure–activity relationships (SAR)
for the ACh enzyme, as described above. These findings should be considered
by pharmaceutical chemists working on the design of potential new
dual inhibitors for anti-Alzheimer’s therapy.</p>
<p>Additionally,
using the SwissADME web tool, the BBB
permeability was predicted for the synthesized
compounds. Compounds were not determined as positive. The blood–brain
barrier (BBB) leakage is commonly observed in the early pathological
stages of Alzheimer’s disease, and is now considered one of its characteristic features. Therefore,
while designing compounds with BBB permeability is beneficial, it
may not always be an essential prerequisite for anti-Alzheimer disease
activity.</p>
<p>Nevertheless, the lack of BBB permeability in the
current active
compounds as predicted, despite their strong in vitro enzyme inhibition
profiles, the structural modifications aimed at improving BBB permeability
or the use of drug delivery systems to facilitate central nervous
system targeting may be considered for further studies. These considerations
have been briefly mentioned in the manuscript as part of future perspectives.</p></section></section></section><section id="sec3"><h2 class="pmc_sec_title">3. Conclusions</h2>
<p>In this study, 15 novel
hybrids, benzofuran-azacyclics, were designed
and synthesized to investigate the theory of “anti-Alzheimer’s
effects of the tubular form with the stopper.” The structures
of these compounds were confirmed by HRMS, <sup>1</sup>H NMR, and <sup>13</sup>C NMR techniques. The final compounds (<strong>4a–4o</strong>) were first evaluated for their inhibitory potency on AChE, followed
by testing the active molecules (<strong>4e</strong>, <strong>4h</strong>, <strong>4m</strong>, and <strong>4o</strong>) against the BACE-1 enzyme. The findings
were further analyzed using in silico methods to clarify their binding
modes. Subsequently, the structure–activity relationships (SARs)
were proposed for future studies. The results indicated that compound <strong>4m</strong>, which contains <em>N</em>-(2-hydroxyethyl)­piperazine
and benzofuran moieties, was the most potent. These moieties effectively
occupied the substrate channel of the AChE enzyme and the catalytic
cleft of the BACE-1 enzyme. Compounds <strong>4e</strong> (benzyl piperidine)
and <strong>4h</strong> (2-furoyl piperazine) analogs exhibited dual inhibitory
activity against both enzymes. In conclusion, the tubular form with
the stopper shows great potential for Alzheimer’s disease treatment,
as it blocks the entrance cavity of the AChE active pocket and enhances
the stability of the inactive BACE-1 enzyme. Moreover, electrolytes
(such as sodium in this case) play a pivotal role in stabilizing the <strong>4m</strong>-BACE-1 protein complex. These findings suggest that the
synthesized compounds exhibit promising inhibitory activity across
multiple enzymatic pathways. Importantly, beyond the identification
of novel bioactive molecules, this study demonstrates that compounds
adopting a nonclassical architecture, specifically, a “tubular
form with the stopper”, may also serve as effective enzyme
inhibitors, challenging the traditional design approaches. Moreover,
based on the current molecular scaffold, future studies may explore
structural modifications or drug delivery systems to enhance pharmacokinetic
properties, including improvements in BBB permeability, thereby supporting
further preclinical development.</p></section><section id="sec4"><h2 class="pmc_sec_title">4. Materials and Methods</h2>
<section id="sec4.1"><h3 class="pmc_sec_title">4.1. Chemistry</h3>
<p>All chemical substances
were purchased from Sigma-Aldrich Chemical Co (Sigma-Aldrich Corp.,
St. Louis, MO, USA) and Merck Chemicals (Merck KGaA, Darmstadt, Germany).
The melting points (mp) of all compounds were determined using a MP90
digital melting point apparatus (Mettler Toledo, Ohio, USA) and were
uncorrected. Reactions were monitored using thin-layer chromatography
(TLC) on Silica Gel 60 F254 plates (Merck KGaA, Darmstadt, Germany).
Petroleum ether-ethyl acetate (3:1) was used as the mobile phase.
Spectroscopic data were recorded using the following instruments: <sup>1</sup>H- and <sup>1</sup>C NMR spectra were obtained on a Bruker
DPX-300 FT-NMR spectrometer (Bruker Bioscience, Billerica, MA, USA)
in DMSO-<em>d</em>
<sub>6</sub>, with TMS as the internal standard.
High-resolution mass spectra (HRMS) were recorded on a Shimadzu 8040
LC/MS/MS system (Shimadzu, Tokyo, Japan). Detailed spectral data can
be found in the <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c01432/suppl_file/ao5c01432_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Supporting Information</a>.</p>
<section id="sec4.1.1"><h4 class="pmc_sec_title">4.1.1. General Synthesis of (3-Methylbenzofuran-2-yl)­(phenyl)­methanone
(<strong>1</strong>)</h4>
<p>2′-Hydroxyacetophenone (5 mmol),
2-bromoacetophenone (5 mmol), and potassium carbonate (6 mmol) were
stirred in acetonitrile under reflux for 4 h. The reaction progress
was monitored using TLC. After the reaction, the solvent was completely
evaporated, and the solid was washed with water, filtered, and dried.
The product was crystallized from ethanol.</p></section><section id="sec4.1.2"><h4 class="pmc_sec_title">4.1.2. General Synthesis of (3-(Bromomethyl)­benzofuran-2-yl)­(phenyl)­metanone
(<strong>2</strong>)</h4>
<p>(3-Methylbenzofuran-2-yl)­(phenyl)­methanone
(1) (5 mmol), <em>N</em>-bromosuccinimide (NBS) (5 mmol),
and benzoylperoxide (5 mmol) were stirred at reflux in CCl4 for 5
h. After the reaction, the solvent was evaporated, and the solid was
washed first with water, then with cold alcohol, filtered, and dried.</p></section><section id="sec4.1.3"><h4 class="pmc_sec_title">4.1.3. Sodium/Potassium <em>N</em>,<em>N</em>-Disubstituted Dithiocarbamate Salt Synthesis (<strong>3a</strong>–<strong>o</strong>)</h4>
<p>An inorganic base (sodium/potassium
hydroxide) (0.01 mol) was dissolved in ethanol (100 mL) with continuous
stirring. After adding the secondary amine (0.01 mol), the mixture
was cooled in an ice bath, and carbon disulfide (0.10 mol) was added
dropwise with stirring. The reaction mixture was stirred for another
hour at room temperature. Afterward, the solvent was evaporated under
reduced pressure, and ether was added until precipitation occurred.
The precipitate was filtered, and the product was crystallized from
ethanol.</p></section><section id="sec4.1.4"><h4 class="pmc_sec_title">4.1.4. Synthesis of (2-Benzoyl Benzofuran-3-yl)­methyl <em>N</em>,<em>N</em>-Disubstituted-1-carbodithioate Derivatives
(<strong>4a</strong>–<strong>o</strong>)</h4>
<p>[3-(Bromomethyl)­benzofuran-2-yl]­(phenyl)­methanone
(<strong>2</strong>) (0.01 mmol) and the appropriate dithiocarbamate metal
salt derivatives (<strong>3a</strong>–<strong>o</strong>) (0.01 mmol)
were stirred in acetone at room temperature for 4 h. The solvent was
completely evaporated, the solid was washed with water, filtered and
then dried. The products were crystallized from ethanol.</p>
<section id="sec4.1.4.1"><h5 class="pmc_sec_title">4.1.4.1. (2-Benzoylbenzofuran-3-yl)­methylpiperidine-1-dithiocarbamate
(<strong>4a</strong>)</h5>
<p>mp 142 °C. Yield % 82. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 1.54–1.59
(6H, m, piperidine-CH<sub>2</sub>), 3.82 (2H, s, piperidine-CH<sub>2</sub>), 4.22 (2H, s, piperidine-CH<sub>2</sub>), 5.07 (2H, s, S–CH<sub>2</sub>), 7.41 (H, t, <em>J</em> = 7.6 Hz, Ar–H),
7.55–7.63 (3H, m, Ar–H), 7.72 (2H, t, <em>J</em> = 7.9 Hz, Ar–H), 7.95 (H, d, <em>J</em> = 7.71 Hz,
Ar–H), 8.00–8.03 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 23.97
(C, s, piperidine-CH<sub>2</sub>), 25.70 (C, s, piperidine-CH<sub>2</sub>), 26.27 (C, s, piperidine-CH<sub>2</sub>), 31.48 (C, s, CH<sub>2</sub>), 51.42 (C, s, piperidine-CH<sub>2</sub>), 53.13 (C, s, piperidine-CH<sub>2</sub>), 112.98, 122.90, 124.49, 125.12, 127.32, 129.11, 129.32,
130.03, 133.76, 137.22, 148.94, 154.14, 185.41 (C, s, CO),
193.20 (C, s, CS). LCMSMS (-<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>22</sub>H<sub>21</sub>NO<sub>2</sub>S<sub>2</sub>; found, 396.15.</p></section><section id="sec4.1.4.2"><h5 class="pmc_sec_title">4.1.4.2. (2-Benzoylbenzofuran-3-yl)­methyl 2-Methylpiperidine-1-dithiocarbamate
(<strong>4b</strong>)</h5>
<p>mp 103 °C. Yield % 84. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 1.16
(3H, d, <em>J</em> = 6.86 Hz, piperidine-CH<sub>3</sub>),
1.47–1.68 (6H, m, piperidine-CH<sub>2</sub>), 2.85–3.19
(2H, m, piperidine-CH<sub>2</sub>), 4.25–4.41 (1H, m, piperidine-CH),
5.06 (2H, s, S–CH<sub>2</sub>), 7.39 (2H, t, <em>J</em> = 7.48 Hz, Ar–H), 7.77–7.71 (3H, m, Ar–H),
7.93 (H, d, <em>J</em> = 7.79 Hz, Ar–H), 7.99–8.02
(3H, m, Ar–H). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>23</sub>H<sub>23</sub>NO<sub>2</sub>S<sub>2</sub>; found, 410.15.</p></section><section id="sec4.1.4.3"><h5 class="pmc_sec_title">4.1.4.3. (2-Benzoylbenzofuran-3-yl)­methyl 3-Methylpiperidine-1-dithiocarbamate
(<strong>4c</strong>)</h5>
<p>mp 117 °C. Yield % 74. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 0.86–0.84
(3H, m, piperidine-CH<sub>3</sub>), 1.13–1.75 (6H, m, piperidine-CH<sub>2</sub>), 3.30–2.89 (2H, m, piperidine-CH<sub>2</sub>), 4.32–4.18
(H, m, piperidine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 7.37–7.42 (H, m, Ar–H), 7.53–7.58 (H, m,
Ar–H), 7.59–7.62 (2H, m, Ar–H), 7.67–7.73
(2H, m, Ar–H), 7.93 (H, d, <em>J</em> = 7.7 Hz, Ar–H),
7.80–8.03 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz,
DMSO-<em>d</em>
<sub>6</sub>): δ 19.06 (C, s, piperidine-<span class="text-underline">CH</span>
<sub>3</sub>), 25.52 (C, s, piperidine-CH<sub>2</sub>), 31.53 (C, s, piperidine-CH<sub>2</sub>), 32.40 (C, s, piperidine-<span class="text-underline">CH</span>), 52.69 (C, s, piperidine-CH<sub>2</sub>), 58.78 (C,
s, piperidine-CH<sub>2</sub>), 112.94, 122.87, 124.46, 125.10, 127.32,
129.08, 129.29, 130.03, 133.74, 137.20, 148.93, 154.12, 185.36 (C,
s, CO), 193.36 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>23</sub>H<sub>23</sub>NO<sub>2</sub>S<sub>2</sub>; found, 410.10.</p></section><section id="sec4.1.4.4"><h5 class="pmc_sec_title">4.1.4.4. (2-Benzoylbenzofuran-3-yl)­methyl 4-Methylpiperidine-1-dithiocarbamate
(<strong>4d</strong>)</h5>
<p>mp 100 °C. Yield % 82. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 0.85
(3H, s, piperidine-CH<sub>3</sub>), 0.98–1.05 (2H, m, piperidine-CH<sub>2</sub>), 1.64–1.67 (4H, m, piperidine-CH<sub>2</sub>), 3.11–3.27
(2H, m, piperidine-CH<sub>2</sub>), 4.34–4.41 (H, m, piperidine-CH),
5.05 (2H, s, S–CH<sub>2</sub>), 7.36–7.41 (H, m, Ar–H),
7.52–7.61 (3H, m, Ar–H), 7.67–7.71 (2H, m, Ar–H),
7.99–8.02 (3H, s, Ar–H). <sup>13</sup>C NMR (75 MHz,
DMSO-<em>d</em>
<sub>6</sub>): δ 21.47 (C, s, piperidine-CH<sub>3</sub>), 30.42 (C, s, CH<sub>2</sub>), 31.56 (C, s, piperidine-CH),
33.66 (C, s, piperidine-CH<sub>2</sub>), 34.17 (C, s, piperidine-CH<sub>2</sub>), 50.49 (C, s, piperidine-CH<sub>2</sub>), 52.34 (C, s, piperidine-CH<sub>2</sub>), 112.92, 122.88, 124.43, 125.15, 127.31, 129.10, 129.07,
129.27, 133.72, 137.19, 148.92, 154.12, 185.32 (C, s, CO),
193.38 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>23</sub>H<sub>23</sub>NO<sub>2</sub>S<sub>2</sub>; found, 410.10.</p></section><section id="sec4.1.4.5"><h5 class="pmc_sec_title">4.1.4.5. (2-Benzoylbenzofuran-3-yl)­methyl 4-Benzylpiperidine-1-dithiocarbamate
(<strong>4e</strong>)</h5>
<p>mp 54 °C. Yield % 81. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 1.60–1.86
(4H, m, piperidine-CH<sub>2</sub>), 2.08 (H, s, piperidine-CH), 2.46
(2H, d, <em>J</em> = 6.88 Hz, phenyl-CH<sub>2</sub>), 3.09–3.53
(4H, m, piperidine-CH<sub>2</sub>), 5.06 (2H, s, S–CH<sub>2</sub>), 7.12–7.28 (3H, m, Ar–H), 7.25 (3H, t, <em>J</em> = 7.4 Hz, Ar–H), 7.38–7.43 (H, m, Ar–H), 7.54.-7.62
(3H, m, Ar–H), 7.68–7.74 (2H, m, Ar–H), 7.94
(H, d, <em>J</em> = 7.9 Hz, Ar–H), 8.03 (H, s, CH–Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ
31.56 (2C, s, piperidine-CH<sub>2</sub>), 32.09 (C, s, CH<sub>2</sub>), 37.40 (C, s, piperidine-CH), 41.92 (C, s, phenyl-CH<sub>2</sub>), 50.44 (C, s, piperidine-CH<sub>2</sub>), 52.21 (C, s, piperidine-CH<sub>2</sub>), 112.97, 122.90, 125.1, 124.49, 125.11, 126.36, 127.32,
128.65, 129.10, 129.45, 130.03, 133.76, 137.21, 140.29, 148.93, 154.13,
185.38 (C, s, CO), 193.35 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>29</sub>H<sub>27</sub>NO<sub>2</sub>S<sub>2</sub>; found, 486.20.</p></section><section id="sec4.1.4.6"><h5 class="pmc_sec_title">4.1.4.6. (2-Benzoylbenzofuran-3-yl)­methyl Morpholine-4-dithiocarbamate
(<strong>4f</strong>)</h5>
<p>mp 121 °C. Yield % 85. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.64
(4H, s, morpholine-CH2), 3.87–4.22 (4H, m, morpholine-CH2),
5.08 (2H, s, S–CH2), 7.40–7.45 (H, m, Ar–H),
7.56–7.58 (H, m, Ar–H), 7.59–7.63 (2H, m, Ar–H),
7.69–7.75 (2H, m, Ar–H), 7.96 (H, d, <em>J</em> = 7.8 Hz, Ar–H), 8.01–8.04 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ
31.20 (C, s, CH2), 50.65 (C, s, morpholine-CH<sub>2</sub>), 51.82
(C, s, morpholine-CH<sub>2</sub>), 6.03 (2C, s, morpholine-CH<sub>2</sub>), 112.99, 122.88, 124.53, 124.88, 127.30, 129.12, 129.35,
130.04, 133.80, 137.17, 149.02, 154.13, 185.39 (C, s, CO),
195.12 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): <strong>[M + H]</strong>
<sup>
<strong>+</strong>
</sup> For C<sub>21</sub>H<sub>19</sub>NO<sub>3</sub>S<sub>2</sub>; found, 398.10.</p></section><section id="sec4.1.4.7"><h5 class="pmc_sec_title">4.1.4.7. (2-Benzoylbenzofuran-3-yl)­methyl 4-(3-(Dimethylamino)­propyl)­piperazine-1-dithiocarbamate
(<strong>4g</strong>)</h5>
<p>mp 158 °C. Yield % 86. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 1.73–1.78
(2H, m, –CH<sub>2</sub>–CH<sub>2</sub>–<span class="text-underline">CH</span>
<sub>2</sub>–<em>N</em>–), 2.33–2.43
(6H, m, <em>N</em>-(CH<sub>3</sub>)<sub>2</sub>), 2.67 (6H,
s, piperazine-CH<sub>2</sub>), 2.92–2.97 (2H, m, –CH<sub>2</sub>–<span class="text-underline">CH</span>
<sub>2</sub>–CH<sub>2</sub>–N–), 3.86–4.24 (4H, m, piperazine-CH<sub>2</sub> ve –<span class="text-underline">CH</span>
<sub>2</sub>-CH<sub>2</sub>–CH<sub>2</sub>–N–), 5.07 (2H, s, S–CH<sub>2</sub>), 7.39–7.45 (H, m, Ar–H), 7.58–7.63
(3H, m, Ar–H), 7.70–7.75 (2H, m, Ar–H), 7.95
(H, d, <em>J</em> = 8.82 Hz, Ar–H), 8.00–8.04
(2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 21.82 (C, s, –CH<sub>2</sub>–<span class="text-underline">CH</span>
<sub>2</sub>–CH<sub>2</sub>–N–),
31.39 (C, s, CH<sub>2</sub>), 43.09 (2C, s, <em>N</em>-(CH<sub>3</sub>)<sub>2</sub>), 51.58 (C, s, –<span class="text-underline">CH</span>
<sub>2</sub>–CH<sub>2</sub>–CH<sub>2</sub>–N–),
52.34 (C, s, –CH<sub>2</sub>–CH<sub>2</sub>–<span class="text-underline">CH</span>
<sub>2</sub>–<em>N</em>–), 54.47
(2C, s, piperazine-CH<sub>2</sub>), 55.99 (2C, s, piperazine-CH<sub>2</sub>), 113.01, 122.88, 124.53, 124.94, 127.29, 129.14, 129.37,
130.04, 130.38, 133.82, 137.17, 148.99, 154.13, 185.40 (C, s, CO),
194.53 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>26</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub>; found, 482.20.</p></section><section id="sec4.1.4.8"><h5 class="pmc_sec_title">4.1.4.8. (2-Benzoylbenzofuran-3-yl)­methyl 4-(Furan-2-carbonyl)­piperazine-1-dithiocarbamate
(<strong>4h</strong>)</h5>
<p>mp 150 °C. Yield % 75. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.42–3.82
(4H, m, piperazine-CH<sub>2</sub>), 4.00–4.33 (4H, m, piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 6.64 (H, q, <em>J</em>1 = 1.77 Hz, <em>J</em>2 = 3.48 Hz, Ar–H),
7.05 (H, d, <em>J</em> = 3.45 Hz, Ar–H), 7.41–7.46
(H, m, Ar–H), 7.57–7.64 (3H, m, Ar–H),7.70–7.77
(2H, m, Ar–H), 7.86–7.87 (H, m, Ar–H), 7.98 (H,
d, <em>J</em> = 7.8 Hz, Ar–H), 8.02–8.05 (2H,
m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 31.32 (C, s, CH<sub>2</sub>), 49.36 (2C, s,
piperazine-CH<sub>2</sub>), 51.09 (2C, s, piperazine-CH<sub>2</sub>), 111.91, 113.01, 116.60, 122.91, 124.55, 124.88, 127.30, 129.14,
129.38, 130.06, 133.82, 137.18, 145.61, 147.03, 149.05, 154.15, 158.87,
185.41 (C, s, CO), 195.05 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>26</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>; found, 491.15.</p></section><section id="sec4.1.4.9"><h5 class="pmc_sec_title">4.1.4.9. (2-Benzoylbenzofuran-3-yl)­methyl 4-(Pyrimidine-2-yl)­piperazine-1-dithiocarbamate
(<strong>4i</strong>)</h5>
<p>mp 155 °C. Yield % 70. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.84
(4H, s, piperazine-CH2), 3.99 (2H, s, piperazine-CH2), 4.34 (2H, s,
piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>),
6.67 (H, t, <em>J</em> = 4.74 Hz, Ar–H), 7.39–7.45
(H, m, Ar–H), 7.56–7.63 (3H, m, Ar–H), 7.69–7.75
(2H, m, Ar–H), 7.98 (H, d, <em>J</em> = 7.02 Hz, Ar–H),
8.02–8.05 (2H, m, Ar–H), 8.37 (H, s, Ar–H), 8.39
(H, s, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 31.34 (C, s, CH2), 49.62 (2C, s, piperazine-CH<sub>2</sub>), 51.23 (2C, s, piperazine-CH<sub>2</sub>), 111.05, 113.00,
122.90, 124.54, 124.94, 127.30, 129.12, 129.36, 130.05, 133.80, 137.18,
149.03, 154.14, 158.44, 161.14, 185.38 (C, s, CO), 194.88
(C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>25</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>S<sub>2</sub>; found, 475.15.</p></section><section id="sec4.1.4.10"><h5 class="pmc_sec_title">4.1.4.10. (2-Benzoylbenzofuran-3-yl)­methyl 4-Phenylpiperazine-1-dithiocarbamate
(<strong>4j</strong>)</h5>
<p>mp 122 °C. Yield % 79. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.25
(4H, s, piperazine-CH<sub>2</sub>), 4.01 (2H, s, piperazine-CH<sub>2</sub>), 4.37 (2H, s, piperazine-CH<sub>2</sub>), 5.01 (2H, s, S–CH<sub>2</sub>), 6.79 (H, t, <em>J</em> = 7.2 Hz, Ar–H),
6.91 (2H, d, <em>J</em> = 7.95 Hz, Ar–H), 7.19–7.24
(2H, m, Ar–H), 7.39–7.44 (H, m, Ar–H), 7.55–7.58
(H, m, Ar–H), 7.59–7.63 (2H, m, Ar–H), 7.72 (2H,
t, <em>J</em> = 8.5 Hz, Ar–H), 7.97 (H, d, <em>J</em> = 7.8 Hz, Ar–H), 8.01–8.04 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ
31.38 (C, s, CH<sub>2</sub>), 49.72 (2C, s, piperazine-CH<sub>2</sub>), 51.29 (2C, s, piperazine-CH<sub>2</sub>), 112.99, 115.97, 119.86,
122.91, 124.52, 124.96, 127.31, 129.12, 129.35, 130.05, 133.79, 137.19,
149.02, 150.34, 154.14, 185.39 (C, s, CO), 194.76 (C, s, CS).
LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>27</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub>; found, 473.20.</p></section><section id="sec4.1.4.11"><h5 class="pmc_sec_title">4.1.4.11. (2-Benzoylbenzofuran-3-yl)­methyl 4-(4-Nitrophenyl)­piperazine-1-dithiocarbamate
(<strong>4k</strong>)</h5>
<p>mp 181 °C. Yield % 80. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.68
(4H, s, piperazine-CH<sub>2</sub>), 4.05 (2H, s, piperazine-CH<sub>2</sub>), 4.37 (2H, s, piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 6.90 (2H, d, <em>J</em> = 9.5 Hz, Ar–H),
7.40–7.45 (H, m, Ar–H), 7.56–7.58 (H, m, Ar–H),
7.59–7.64 (2H, m, Ar–H), 7.69–7.76 (2H, m, Ar–H),
7.98 (H, d, <em>J</em> = 6.03 Hz, Ar–H), 8.02–8.09
(4H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 31.25 (C, s, CH<sub>2</sub>), 48.70 (2C, s,
piperazine-CH<sub>2</sub>), 50.61 (C, s, piperazine-CH<sub>2</sub>), 112.20, 113.01, 122.92, 124.54, 124.94, 126.26, 127.29, 129.14,
129.37, 130.06, 130.50, 133.82, 137.17, 137.20, 149.05, 154.08, 154.14,
185.40 (C, s, CO), 194.85 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>27</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>; found, 518.15.</p></section><section id="sec4.1.4.12"><h5 class="pmc_sec_title">4.1.4.12. (2-Benzoylbenzofuran-3-yl)­methyl 4-(4-Methoxyphenyl)­piperazine-1-dithiocarbamate
(<strong>4l</strong>)</h5>
<p>mp 108 °C. Yield % 88. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.10
(2H, s, piperazine-CH<sub>2</sub>), 3.45 (2H, s, piperazine-CH<sub>2</sub>), 3.67 (3H, s, O–CH3), 4.01 (2H, s, piperazine-CH<sub>2</sub>), 4.38 (2H, s, piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 6.81–6.84 (2H, m, Ar–H), 6.91 (2H, d, <em>J</em> = 9.18 Hz, Ar–H), 7.43 (H, t, <em>J</em> = 7.60 Hz, Ar–H), 7.56–7.59 (H, m, Ar–H), 7.61–7.64
(2H, m, Ar–H), 7.70–7.77 (2H, m, Ar–H), 7.98
(H, d, <em>J</em> = 7.86 Hz, Ar–H), 8.01–8.05
(2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 31.39 (C. s, CH<sub>2</sub>), 49.86 (4C, s,
piperazine-CH<sub>2</sub>), 55.63 (C, s, O–CH<sub>3</sub>),
113.01, 114.77, 118.42, 122.91, 124.54, 124.94, 127.31, 129.14, 129.37,
130.05, 133.81, 137.20, 144.72, 149.02, 154.15, 185.42 (C, s, CO),
194.73 (C, s, CS). LCMSMS (–<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>28</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub>; found, 503.20.</p></section><section id="sec4.1.4.13"><h5 class="pmc_sec_title">4.1.4.13. (2-Benzoylbenzofuran-3-yl)­methyl 4-(2-Hydroxyethyl)­piperazine-1-dithiocarbamate
(<strong>4m</strong>)</h5>
<p>mp 127 °C. Yield % 86. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 2.47
(2H, t, <em>J</em> = 5.99 Hz, HO–CH<sub>2</sub>–<span class="text-underline">CH</span>
<sub>2</sub>–), 2.54 (4H, s, piperazine-CH<sub>2</sub>), 3.52 (2H, t, <em>J</em> = 5.94 Hz, HO–<span class="text-underline">CH</span>
<sub>2</sub>–CH<sub>2</sub>−), 3.86 (2H,
s, piperazine-CH<sub>2</sub>), 4.24 (2H, s, piperazine-CH<sub>2</sub>), 4.54 (H, s, –OH), 5.06 (2H, s, S–CH<sub>2</sub>),
7.36–7.42 (H, m, Ar–H), 7.52–7.61 (3H, m, Ar–H),
7.671–7.71 (2H, m, Ar–H), 7.93 (H, d, <em>J</em> = 7.8 Hz, Ar–H), 8.00–8.02 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ
31.46 (C, s, CH<sub>2</sub>), 49.89 (2C, s, piperazine-CH<sub>2</sub>), 51.34 (C, s, piperazine-CH<sub>2</sub>), 52.78 (C, s, piperazine-CH<sub>2</sub>), 58.62 (C, s, hydroxyethyl- CH<sub>2</sub>), 59.75 (C, s,
hydroxyethyl-CH<sub>2</sub>), 112.93, 122.85, 124.46, 124.96, 127.29,
129.08, 130.01, 133.73, 137.18, 148.98, 154.12, 185.30 (C, s, CO),
194.64 (C, s, CS). LCMSMS (-<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>23</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub>; found, 441.10.</p></section><section id="sec4.1.4.14"><h5 class="pmc_sec_title">4.1.4.14. (2-Benzoylbenzofuran-3-yl)­methyl 4-(4-Chlorophenyl)­piperazine-1-dithiocarbamate
(<strong>4n</strong>)</h5>
<p>mp 93 °C. Yield % 77. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.49
(4H, s, piperazine-CH<sub>2</sub>), 4.02 (2H, s, piperazine-CH<sub>2</sub>), 4.38 (2H, s, piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 6.92 (2H, d, <em>J</em> = 9.10 Hz, Ar–H),
7.24 (2H, d, <em>J</em> = 8.9 Hz, Ar–H), 7.35–7.45
(2H, m, Ar–H), 7.57–7.64 (2H, m, Ar–H), 7.69–7.76
(2H, m, Ar–H), 7.87 (H, d, <em>J</em> = 8.01 Hz, Ar–H),
7.97–8.05 (2H, m, Ar–H). <sup>13</sup>C NMR (75 MHz,
DMSO-<em>d</em>
<sub>6</sub>): δ 31.38 (C, s, CH<sub>2</sub>), 47.68 (4C, s, piperazine-CH<sub>2</sub>), 112.99, 117.21,
117.86, 122.90, 123.13, 124.53, 124.91, 127.32, 129.13, 129.18, 129.35,
130.03, 133.79, 137.21, 149.04, 149.23, 154.16, 185.42 (C, s, CO),
194.84 (C, s, CS). LCMSMS (-<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>27</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>2</sub>S<sub>2</sub>; found, 507.15.</p></section><section id="sec4.1.4.15"><h5 class="pmc_sec_title">4.1.4.15. (2-Benzoylbenzofuran-3-yl)­methyl 4-(4-Fluorophenyl)­piperazine-1-dithiocarbamate
(<strong>4o</strong>)</h5>
<p>mp 109 °C. Yield % 73. <sup>1</sup>H NMR (300 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 3.16
(4H, s, piperazin-CH<sub>2</sub>), 4.00 (2H, s, piperazine-CH<sub>2</sub>), 4.37 (2H, s, piperazine-CH<sub>2</sub>), 5.10 (2H, s, S–CH<sub>2</sub>), 6.89–6.94 (2H, m, Ar–H), 7.04 (2H, t, <em>J</em> = 8.85 Hz, Ar–H), 7.40 (H, t, <em>J</em> = 7.25 Hz, Ar–H), 7.54–7.62 (3H, m, Ar–H),
7.70 (2H, t, <em>J</em> = 7.32 Hz, Ar–H), 7.97 (H,
d, <em>J</em> = 7.8 Hz, Ar–H), 8.02–8.05 (2H,
m, Ar–H). <sup>13</sup>C NMR (75 MHz, DMSO-<em>d</em>
<sub>6</sub>): δ 31.45 (C, s, CH<sub>2</sub>), 48.92 (2C, s,
piperazine-CH<sub>2</sub>), 49.81 (C, s, piperazine-CH<sub>2</sub>), 51.31 (C, s, piperazine-CH<sub>2</sub>), 112.94, 115.70 ve 115.99,
117.80, 117.90, 122.88, 124.48, 124.97, 127.32, 129.08, 129.31, 130.03,
133.74, 137.19, 147.34, 147.36, 149.02, 154.15, 155.19 ve 158.32,
185.31 (C, s, CO), 194.89 (C, s, CS). LCMSMS (-<em>m</em>/<em>z</em>): [M + H]<sup>+</sup> For C<sub>27</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>2</sub>S<sub>2</sub>; found, 491.15.</p></section></section></section><section id="sec4.2"><h3 class="pmc_sec_title">4.2. Cholinesterase Activity</h3>
<p>According
to the modified Ellman approach outlined in our earlier works<em>
−

</em> the AChE and BChE inhibitory activities of the obtained compounds
were evaluated. The enzymes utilized in the experiment were human
AChE (CAS no. 9000-81-1) and human BChE (CAS no. 9001-08-5).</p></section><section id="sec4.3"><h3 class="pmc_sec_title">4.3. β-Secretase Activity</h3>
<p>The experimental
procedure was based on the “Human β-Secretase (BACE-1)
Inhibitor Screening Assay” kit (Human β-Secretase (BACE1)
Inhibitor Screening Kit (Fluorometric)-Catalog no: K720-100) protocol
based on the fluorometric method as performed previously.
</p></section><section id="sec4.4"><h3 class="pmc_sec_title">4.4. Kinetic Studies of AChE Enzyme Inhibition</h3>
<p>The compound <strong>4m</strong>, which was found to be the most effective
derivative in the series, was included in the enzyme kinetics study
to assign the type of inhibition. For this purpose, this compound
was prepared at different concentrations (IC<sub>50</sub>, 2xIC<sub>50</sub> and IC<sub>50/2</sub>). Moreover, a substrate (ATC) was
used at various concentrations (600, 300, 150, 75, 37.5, and 18.75
μM). The enzyme kinetics assay was carried out as in our previous.<em>
−

</em> Lineweaver–Burk plots were formed using Microsoft Office
Excel 2013. The <em>K</em>
<sub>i</sub> values of the compound
were easily calculated from the second plot with a common intercept
on the <em>x</em>-axis (corresponding to –<em>K</em>
<sub>i</sub>).</p></section><section id="sec4.5"><h3 class="pmc_sec_title">4.5. Molecular Docking and Molecular Dynamics Simulation
(MDS) Studies</h3>
<p>The in silico docking procedure was applied
to understand potential interactions, which point out to us what’s
the relation between ligands and acetylcholinesterase and β-secretase
enzymes (PDBID: <a href="https://www.rcsb.org/structure/4EY7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">4EY7</a> and <a href="https://www.rcsb.org/structure/2ZJM" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">2ZJM</a>,
respectively). Herewith, it helps us to understand the behavior of
how active compounds act in the active region of the enzyme. Considering
in vitro enzyme tests, compounds <strong>4e</strong>, <strong>4h</strong>, <strong>4m</strong>, and <strong>4o</strong> were docked into AChE active pocket
and BACE-1 binding cavity using structure-based in silico docking
procedure.<em>
,−


</em> After docking studies, to understand
environmental effects regarding time on the stability and behavior
of ligand–protein complex, the most active compound on both
enzymes, <strong>4m</strong>, was used as a model for its analogs. The
MDS method for 100 ns simulation time was applied the same as performed
previously by our team.<em>
,−


</em>
</p></section></section><section id="sec37"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sifile1"><div class="media p"><div class="caption">
<a href="/articles/instance/12332554/bin/ao5c01432_si_001.pdf" data-ga-action="click_feat_suppl" class="usa-link">ao5c01432_si_001.pdf</a><sup> (2.2MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We gratefully thank Anadolu University for performing
analytical measurements. The videos can be watched via <a href="https://youtu.be/ayVHFIlXq1Y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://youtu.be/ayVHFIlXq1Y</a> (Video 1) and <a href="https://youtu.be/3zdwynpUxGc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://youtu.be/3zdwynpUxGc</a> (Video 2).</p></section><section id="notes1"><p>The Supporting
Information is
available free of charge at <a href="https://pubs.acs.org/doi/10.1021/acsomega.5c01432?goto=supporting-info" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubs.acs.org/doi/10.1021/acsomega.5c01432</a>.</p>
<ul id="silist" class="list" style="list-style-type:none"><li><p>Includes the characterization data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, and MS) for the synthesized compounds; this additional
material provides further confirmation and details relevant to the
experimental section of the manuscript (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c01432/suppl_file/ao5c01432_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PDF</a>)</p></li></ul></section><section id="notes2"><p>The authors
declare no competing financial interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Canudas-Romo V.. Three measures
of longevity: Time trends and record values. Demography. 2010;47:299–312. doi: 10.1353/dem.0.0098.</cite> [<a href="https://doi.org/10.1353/dem.0.0098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3000019/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20608098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Demography&amp;title=Three%20measures%20of%20longevity:%20Time%20trends%20and%20record%20values&amp;author=V.%20Canudas-Romo&amp;volume=47&amp;publication_year=2010&amp;pages=299-312&amp;pmid=20608098&amp;doi=10.1353/dem.0.0098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Hugar L. A., Wulff-Burchfield E. M., Winzelberg G. S., Jacobs B. L., Davies B. J.. Incorporating
palliative care principles to improve patient care and quality of
life in urologic oncology. Nat. Rev. Urol. 2021;18(10):623–635. doi: 10.1038/s41585-021-00491-z.</cite> [<a href="https://doi.org/10.1038/s41585-021-00491-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8312356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34312530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Urol&amp;title=Incorporating%20palliative%20care%20principles%20to%20improve%20patient%20care%20and%20quality%20of%20life%20in%20urologic%20oncology&amp;author=L.%20A.%20Hugar&amp;author=E.%20M.%20Wulff-Burchfield&amp;author=G.%20S.%20Winzelberg&amp;author=B.%20L.%20Jacobs&amp;author=B.%20J.%20Davies&amp;volume=18&amp;issue=10&amp;publication_year=2021&amp;pages=623-635&amp;pmid=34312530&amp;doi=10.1038/s41585-021-00491-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Drozdowska D., Maliszewski D., Wróbel A., Ratkiewicz A., Sienkiewicz M.. New Benzamides
as Multi-Targeted Compounds: A Study
on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking. Int. J. Mol. Sci. 2023;24(19):14901. doi: 10.3390/ijms241914901.</cite> [<a href="https://doi.org/10.3390/ijms241914901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10573752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37834347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=New%20Benzamides%20as%20Multi-Targeted%20Compounds:%20A%20Study%20on%20Synthesis,%20AChE%20and%20BACE1%20Inhibitory%20Activity%20and%20Molecular%20Docking&amp;author=D.%20Drozdowska&amp;author=D.%20Maliszewski&amp;author=A.%20Wr%C3%B3bel&amp;author=A.%20Ratkiewicz&amp;author=M.%20Sienkiewicz&amp;volume=24&amp;issue=19&amp;publication_year=2023&amp;pages=14901&amp;pmid=37834347&amp;doi=10.3390/ijms241914901&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>Saglik B. N., Levent S., Osmaniye D., Evren A. E., Karaduman A. B., Ozkay Y., Kaplancikli Z. A.. Design, Synthesis, and In Vitro and
In Silico Approaches of Novel Indanone Derivatives as Multifunctional
Anti-Alzheimer Agents. ACS Omega. 2022;7(50):47378–47404. doi: 10.1021/acsomega.2c06906.</cite> [<a href="https://doi.org/10.1021/acsomega.2c06906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9774391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36570177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Design,%20Synthesis,%20and%20In%20Vitro%20and%20In%20Silico%20Approaches%20of%20Novel%20Indanone%20Derivatives%20as%20Multifunctional%20Anti-Alzheimer%20Agents&amp;author=B.%20N.%20Saglik&amp;author=S.%20Levent&amp;author=D.%20Osmaniye&amp;author=A.%20E.%20Evren&amp;author=A.%20B.%20Karaduman&amp;volume=7&amp;issue=50&amp;publication_year=2022&amp;pages=47378-47404&amp;pmid=36570177&amp;doi=10.1021/acsomega.2c06906&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Iraji A., Khoshneviszadeh M., Firuzi O., Khoshneviszadeh M., Edraki N.. Novel small molecule
therapeutic agents for Alzheimer
disease: Focusing on BACE1 and multi-target directed ligands. Bioorg. Chem. 2020;97:103649. doi: 10.1016/j.bioorg.2020.103649.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2020.103649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32101780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Novel%20small%20molecule%20therapeutic%20agents%20for%20Alzheimer%20disease:%20Focusing%20on%20BACE1%20and%20multi-target%20directed%20ligands&amp;author=A.%20Iraji&amp;author=M.%20Khoshneviszadeh&amp;author=O.%20Firuzi&amp;author=M.%20Khoshneviszadeh&amp;author=N.%20Edraki&amp;volume=97&amp;publication_year=2020&amp;pages=103649&amp;pmid=32101780&amp;doi=10.1016/j.bioorg.2020.103649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Demirayak S., Yurttas L., Cagri Karaburun A., Gundogdu-Karaburun N., Kayagil I.. Synthesis and Antiproliferative Activity
of 2-arylidene
6-(2-aryl-2-oxoethoxy)­Benzofuran-3-one Derivatives. Lett. Drug Des. Discovery. 2016;13(6):563–569. doi: 10.2174/1570180813999160429113316.</cite> [<a href="https://doi.org/10.2174/1570180813999160429113316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lett.%20Drug%20Des.%20Discovery&amp;title=Synthesis%20and%20Antiproliferative%20Activity%20of%202-arylidene%206-(2-aryl-2-oxoethoxy)%C2%ADBenzofuran-3-one%20Derivatives&amp;author=S.%20Demirayak&amp;author=L.%20Yurttas&amp;author=A.%20Cagri%20Karaburun&amp;author=N.%20Gundogdu-Karaburun&amp;author=I.%20Kayagil&amp;volume=13&amp;issue=6&amp;publication_year=2016&amp;pages=563-569&amp;doi=10.2174/1570180813999160429113316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>Gao Y., Ma C., Feng X., Liu Y., Haimiti X.. BF12, a novel benzofuran,
exhibits antitumor activity by inhibiting microtubules and the PI3K/Akt/mTOR
signaling pathway in human cervical cancer cells. Chem. Biodiversity. 2020;17(3):e1900622.  doi: 10.1002/cbdv.201900622.</cite> [<a href="https://doi.org/10.1002/cbdv.201900622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31951313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Biodiversity&amp;title=BF12,%20a%20novel%20benzofuran,%20exhibits%20antitumor%20activity%20by%20inhibiting%20microtubules%20and%20the%20PI3K/Akt/mTOR%20signaling%20pathway%20in%20human%20cervical%20cancer%20cells&amp;author=Y.%20Gao&amp;author=C.%20Ma&amp;author=X.%20Feng&amp;author=Y.%20Liu&amp;author=X.%20Haimiti&amp;volume=17&amp;issue=3&amp;publication_year=2020&amp;pages=e1900622&amp;pmid=31951313&amp;doi=10.1002/cbdv.201900622&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>Eldehna W. M., Nocentini A., Elsayed Z. M., Al-Warhi T., Aljaeed N., Alotaibi O. J., Al-Sanea M. M., Abdel-Aziz H. A., Supuran C. T.. Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase
Inhibitors and Antiproliferative Agents against Breast Cancer. ACS Med. Chem. Lett. 2020;11(5):1022–1027. doi: 10.1021/acsmedchemlett.0c00094.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.0c00094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7236537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32435420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Benzofuran-Based%20Carboxylic%20Acids%20as%20Carbonic%20Anhydrase%20Inhibitors%20and%20Antiproliferative%20Agents%20against%20Breast%20Cancer&amp;author=W.%20M.%20Eldehna&amp;author=A.%20Nocentini&amp;author=Z.%20M.%20Elsayed&amp;author=T.%20Al-Warhi&amp;author=N.%20Aljaeed&amp;volume=11&amp;issue=5&amp;publication_year=2020&amp;pages=1022-1027&amp;pmid=32435420&amp;doi=10.1021/acsmedchemlett.0c00094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>Adalat B., Rahim F., Taha M., Hayat S., Iqbal N., Ali Z., Shah S. A. A., Wadood A., Rehman A. U., Khan K. M.. Synthesis
of Benzofuran–based Schiff bases as anti-diabetic compounds
and their molecular docking studies. J. Mol.
Struct. 2022;1265:133287. doi: 10.1016/j.molstruc.2022.133287.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2022.133287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Synthesis%20of%20Benzofuran%E2%80%93based%20Schiff%20bases%20as%20anti-diabetic%20compounds%20and%20their%20molecular%20docking%20studies&amp;author=B.%20Adalat&amp;author=F.%20Rahim&amp;author=M.%20Taha&amp;author=S.%20Hayat&amp;author=N.%20Iqbal&amp;volume=1265&amp;publication_year=2022&amp;pages=133287&amp;doi=10.1016/j.molstruc.2022.133287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>Abd
El-Karim S. S., Mahmoud A. H., Al-Mokaddem A. K., Ibrahim N. E., Alkahtani H. M., Zen A. A., Anwar M. M.. Development
of a New Benzofuran–Pyrazole–Pyridine-Based Molecule
for the Management of Osteoarthritis. Molecules. 2023;28(19):6814. doi: 10.3390/molecules28196814.</cite> [<a href="https://doi.org/10.3390/molecules28196814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10574112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37836657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Development%20of%20a%20New%20Benzofuran%E2%80%93Pyrazole%E2%80%93Pyridine-Based%20Molecule%20for%20the%20Management%20of%20Osteoarthritis&amp;author=S.%20S.%20Abd%20El-Karim&amp;author=A.%20H.%20Mahmoud&amp;author=A.%20K.%20Al-Mokaddem&amp;author=N.%20E.%20Ibrahim&amp;author=H.%20M.%20Alkahtani&amp;volume=28&amp;issue=19&amp;publication_year=2023&amp;pages=6814&amp;pmid=37836657&amp;doi=10.3390/molecules28196814&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>Shejol V. M., Singh N.. Synthesis and Potential
Anti-Anxiety Activity of Chalcone Benzofuran
Derivatives. NeuroQuantology. 2022;20(19):4109. doi: 10.48047/NQ.2022.20.19.NQ99374.</cite> [<a href="https://doi.org/10.48047/NQ.2022.20.19.NQ99374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NeuroQuantology&amp;title=Synthesis%20and%20Potential%20Anti-Anxiety%20Activity%20of%20Chalcone%20Benzofuran%20Derivatives&amp;author=V.%20M.%20Shejol&amp;author=N.%20Singh&amp;volume=20&amp;issue=19&amp;publication_year=2022&amp;pages=4109&amp;doi=10.48047/NQ.2022.20.19.NQ99374&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Strelow D. N., Magalhães L. S., Paim M. P., Krüger L. D., Neto J. S. S., Brüning C. A., Bortolatto C. F.. Depressive-like
behavior and cognitive impairment induced by acute administration
of dexamethasone: Pharmacological effects of 2-phenyl-3-(phenylselanyl)
benzofuran in female Swiss mice. Prog. Neuro-Psychopharmacol.
Biol. Psychiatry. 2023;125:110772. doi: 10.1016/j.pnpbp.2023.110772.</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2023.110772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37075882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog.%20Neuro-Psychopharmacol.%20Biol.%20Psychiatry&amp;title=Depressive-like%20behavior%20and%20cognitive%20impairment%20induced%20by%20acute%20administration%20of%20dexamethasone:%20Pharmacological%20effects%20of%202-phenyl-3-(phenylselanyl)%20benzofuran%20in%20female%20Swiss%20mice&amp;author=D.%20N.%20Strelow&amp;author=L.%20S.%20Magalh%C3%A3es&amp;author=M.%20P.%20Paim&amp;author=L.%20D.%20Kr%C3%BCger&amp;author=J.%20S.%20S.%20Neto&amp;volume=125&amp;publication_year=2023&amp;pages=110772&amp;pmid=37075882&amp;doi=10.1016/j.pnpbp.2023.110772&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Dawbaa S., Evren A. E., Saglik B. N., Gundogdu-Karaburun N., Karaburun A. C.. Biological activity evaluation of
novel monoamine oxidase
inhibitory compounds targeting Parkinson disease. Future Med. Chem. 2022;14(22):1663–1679. doi: 10.4155/fmc-2022-0167.</cite> [<a href="https://doi.org/10.4155/fmc-2022-0167" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36317547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Future%20Med.%20Chem.&amp;title=Biological%20activity%20evaluation%20of%20novel%20monoamine%20oxidase%20inhibitory%20compounds%20targeting%20Parkinson%20disease&amp;author=S.%20Dawbaa&amp;author=A.%20E.%20Evren&amp;author=B.%20N.%20Saglik&amp;author=N.%20Gundogdu-Karaburun&amp;author=A.%20C.%20Karaburun&amp;volume=14&amp;issue=22&amp;publication_year=2022&amp;pages=1663-1679&amp;pmid=36317547&amp;doi=10.4155/fmc-2022-0167&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>Karaburun A. C.. Synthesis
and Anticandidal Activities of Some Aryl (5-Chloro-Benzofuran- 2-yl)
Ketoximes. Lett. Drug Des. Discovery. 2019;16(4):427–436. doi: 10.2174/1570180816666181207155701.</cite> [<a href="https://doi.org/10.2174/1570180816666181207155701" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lett.%20Drug%20Des.%20Discovery&amp;title=Synthesis%20and%20Anticandidal%20Activities%20of%20Some%20Aryl%20(5-Chloro-Benzofuran-%202-yl)%20Ketoximes&amp;author=A.%20C.%20Karaburun&amp;volume=16&amp;issue=4&amp;publication_year=2019&amp;pages=427-436&amp;doi=10.2174/1570180816666181207155701&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Karaburun A. C. ¸.. Synthesis and Antifungal Activity
of New Nitrobenzofuran Derivatives. J. Osaka
Inst. Sci. Technol. 2019;9:967–974. doi: 10.21597/jist.480052.</cite> [<a href="https://doi.org/10.21597/jist.480052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Osaka%20Inst.%20Sci.%20Technol&amp;title=Synthesis%20and%20Antifungal%20Activity%20of%20New%20Nitrobenzofuran%20Derivatives&amp;author=A.%20C.%20%C2%B8.%20Karaburun&amp;volume=9&amp;publication_year=2019&amp;pages=967-974&amp;doi=10.21597/jist.480052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>Ceyhun İ., Karaca Ş., Osmaniye D., Sağlık B. N., Levent S., Özkay Y., Kaplancıklı Z. A.. Design
and synthesis of novel chalcone derivatives and evaluation of their
inhibitory activities against acetylcholinesterase. Archiv der Pharmazie. 2022;355(3):2100372. doi: 10.1002/ardp.202100372.</cite> [<a href="https://doi.org/10.1002/ardp.202100372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34893996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archiv%20der%20Pharmazie&amp;title=Design%20and%20synthesis%20of%20novel%20chalcone%20derivatives%20and%20evaluation%20of%20their%20inhibitory%20activities%20against%20acetylcholinesterase&amp;author=%C4%B0.%20Ceyhun&amp;author=%C5%9E.%20Karaca&amp;author=D.%20Osmaniye&amp;author=B.%20N.%20Sa%C4%9Fl%C4%B1k&amp;author=S.%20Levent&amp;volume=355&amp;issue=3&amp;publication_year=2022&amp;pages=2100372&amp;pmid=34893996&amp;doi=10.1002/ardp.202100372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>Yilmaz A., Koca M., Boga M., Kurt A., Ozturk T.. Synthesis
of Novel Oxime and Benzofuran Chemical Frameworks Possessing Potent
Anticholinesterase Activity: A SAR Study Related to Alzheimer Disease. ChemistrySelect. 2023;8(30):e202302058.  doi: 10.1002/slct.202302058.</cite> [<a href="https://doi.org/10.1002/slct.202302058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemistrySelect&amp;title=Synthesis%20of%20Novel%20Oxime%20and%20Benzofuran%20Chemical%20Frameworks%20Possessing%20Potent%20Anticholinesterase%20Activity:%20A%20SAR%20Study%20Related%20to%20Alzheimer%20Disease&amp;author=A.%20Yilmaz&amp;author=M.%20Koca&amp;author=M.%20Boga&amp;author=A.%20Kurt&amp;author=T.%20Ozturk&amp;volume=8&amp;issue=30&amp;publication_year=2023&amp;pages=e202302058&amp;doi=10.1002/slct.202302058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Kaur R., Narang S. S., Singh P., Goyal B.. Structural and molecular
insights into tacrine-benzofuran hybrid induced inhibition of amyloid-β
peptide aggregation and BACE1 activity. J. Biomol.
Struct. Dyn. 2023;41:13211–13227. doi: 10.1080/07391102.2023.2191722.</cite> [<a href="https://doi.org/10.1080/07391102.2023.2191722" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37013977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomol.%20Struct.%20Dyn.&amp;title=Structural%20and%20molecular%20insights%20into%20tacrine-benzofuran%20hybrid%20induced%20inhibition%20of%20amyloid-%CE%B2%20peptide%20aggregation%20and%20BACE1%20activity&amp;author=R.%20Kaur&amp;author=S.%20S.%20Narang&amp;author=P.%20Singh&amp;author=B.%20Goyal&amp;volume=41&amp;publication_year=2023&amp;pages=13211-13227&amp;pmid=37013977&amp;doi=10.1080/07391102.2023.2191722&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<cite>Goyal D., Kaur A., Goyal B.. Benzofuran
and Indole: Promising
Scaffolds for Drug Development in Alzheimer’s Disease. ChemMedChem. 2018;13(13):1275–1299. doi: 10.1002/cmdc.201800156.</cite> [<a href="https://doi.org/10.1002/cmdc.201800156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29742314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Benzofuran%20and%20Indole:%20Promising%20Scaffolds%20for%20Drug%20Development%20in%20Alzheimer%E2%80%99s%20Disease&amp;author=D.%20Goyal&amp;author=A.%20Kaur&amp;author=B.%20Goyal&amp;volume=13&amp;issue=13&amp;publication_year=2018&amp;pages=1275-1299&amp;pmid=29742314&amp;doi=10.1002/cmdc.201800156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<cite>Paudel P., Seong S. H., Zhou Y., Ha M. T., Min B. S., Jung H. A., Choi J. S.. Arylbenzofurans from the root bark
of Morus alba as triple inhibitors of cholinesterase, β-site
amyloid precursor protein cleaving enzyme 1, and glycogen synthase
kinase-3β: Relevance to Alzheimer’s disease. ACS omega. 2019;4(4):6283–6294. doi: 10.1021/acsomega.9b00198.</cite> [<a href="https://doi.org/10.1021/acsomega.9b00198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6649263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31459768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20omega&amp;title=Arylbenzofurans%20from%20the%20root%20bark%20of%20Morus%20alba%20as%20triple%20inhibitors%20of%20cholinesterase,%20%CE%B2-site%20amyloid%20precursor%20protein%20cleaving%20enzyme%201,%20and%20glycogen%20synthase%20kinase-3%CE%B2:%20Relevance%20to%20Alzheimer%E2%80%99s%20disease&amp;author=P.%20Paudel&amp;author=S.%20H.%20Seong&amp;author=Y.%20Zhou&amp;author=M.%20T.%20Ha&amp;author=B.%20S.%20Min&amp;volume=4&amp;issue=4&amp;publication_year=2019&amp;pages=6283-6294&amp;pmid=31459768&amp;doi=10.1021/acsomega.9b00198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Yun Y., Miao Y., Sun X., Sun J., Wang X.. Synthesis
and biological evaluation of 2-arylbenzofuran derivatives as potential
anti-Alzheimer’s disease agents. J. Enzyme
Inhib. Med. Chem. 2021;36(1):1345–1355. doi: 10.1080/14756366.2021.1940993.</cite> [<a href="https://doi.org/10.1080/14756366.2021.1940993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8765280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34134572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Enzyme%20Inhib.%20Med.%20Chem.&amp;title=Synthesis%20and%20biological%20evaluation%20of%202-arylbenzofuran%20derivatives%20as%20potential%20anti-Alzheimer%E2%80%99s%20disease%20agents&amp;author=Y.%20Yun&amp;author=Y.%20Miao&amp;author=X.%20Sun&amp;author=J.%20Sun&amp;author=X.%20Wang&amp;volume=36&amp;issue=1&amp;publication_year=2021&amp;pages=1345-1355&amp;pmid=34134572&amp;doi=10.1080/14756366.2021.1940993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<cite>Cui X., Huang Z., Deng S., Zhang Y., Li G., Wang L., Deng Y., Wu C.. Benzofuran Derivatives
from Cortex Mori Radicis and Their Cholinesterase-Inhibitory Activity. Molecules. 2024;29(2):315. doi: 10.3390/molecules29020315.</cite> [<a href="https://doi.org/10.3390/molecules29020315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10820097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38257228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Benzofuran%20Derivatives%20from%20Cortex%20Mori%20Radicis%20and%20Their%20Cholinesterase-Inhibitory%20Activity&amp;author=X.%20Cui&amp;author=Z.%20Huang&amp;author=S.%20Deng&amp;author=Y.%20Zhang&amp;author=G.%20Li&amp;volume=29&amp;issue=2&amp;publication_year=2024&amp;pages=315&amp;pmid=38257228&amp;doi=10.3390/molecules29020315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<cite>Evren A. E., Eksellİ B., YurttaŞ L., Temel H. E., AkalİN
ÇİFtÇİ G.. Design and synthesis of new benzothiazole-piperazine
derivatives and in vitro and in silico investigation of their anticancer
activity. J. Mol. Struct. 2025;1320:139732. doi: 10.1016/j.molstruc.2024.139732.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2024.139732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Design%20and%20synthesis%20of%20new%20benzothiazole-piperazine%20derivatives%20and%20in%20vitro%20and%20in%20silico%20investigation%20of%20their%20anticancer%20activity&amp;author=A.%20E.%20Evren&amp;author=B.%20Eksell%C4%B0&amp;author=L.%20Yurtta%C5%9E&amp;author=H.%20E.%20Temel&amp;author=G.%20Akal%C4%B0N%20%C3%87%C4%B0Ft%C3%87%C4%B0&amp;volume=1320&amp;publication_year=2025&amp;pages=139732&amp;doi=10.1016/j.molstruc.2024.139732&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<cite>Evren A. E., Yurttaş L., Eksellı B., Akalın-Cıftcı G.. Novel Tri-substituted
Thiazoles Bearing Piperazine Ring: Synthesis and Evaluation of their
Anticancer Activity. Lett. Drug Des. Discovery. 2019;16(5):547–555. doi: 10.2174/1570180815666180731122118.</cite> [<a href="https://doi.org/10.2174/1570180815666180731122118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lett.%20Drug%20Des.%20Discovery&amp;title=Novel%20Tri-substituted%20Thiazoles%20Bearing%20Piperazine%20Ring:%20Synthesis%20and%20Evaluation%20of%20their%20Anticancer%20Activity&amp;author=A.%20E.%20Evren&amp;author=L.%20Yurtta%C5%9F&amp;author=B.%20Eksell%C4%B1&amp;author=G.%20Akal%C4%B1n-C%C4%B1ftc%C4%B1&amp;volume=16&amp;issue=5&amp;publication_year=2019&amp;pages=547-555&amp;doi=10.2174/1570180815666180731122118&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<cite>Asha R. N., Sankarganesh M., Bhuvanesh N., Nayagam B. R. D.. Synthesis, structural,
spectral, antidiabetic, DNA interactions and molecular docking investigations
of a piperidine derivative. J. Mol. Struct. 2022;1250:131692. doi: 10.1016/j.molstruc.2021.131692.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2021.131692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Synthesis,%20structural,%20spectral,%20antidiabetic,%20DNA%20interactions%20and%20molecular%20docking%20investigations%20of%20a%20piperidine%20derivative&amp;author=R.%20N.%20Asha&amp;author=M.%20Sankarganesh&amp;author=N.%20Bhuvanesh&amp;author=B.%20R.%20D.%20Nayagam&amp;volume=1250&amp;publication_year=2022&amp;pages=131692&amp;doi=10.1016/j.molstruc.2021.131692&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>Bindu B., Vijayalakshmi S., Manikandan A.. Synthesis and discovery of triazolo-pyridazine-6-yl-substituted
piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl
peptidase-4 inhibition mechanism and insulinotropic activities. Eur. J. Med. Chem. 2020;187:111912. doi: 10.1016/j.ejmech.2019.111912.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.111912" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31812034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20and%20discovery%20of%20triazolo-pyridazine-6-yl-substituted%20piperazines%20as%20effective%20anti-diabetic%20drugs;%20evaluated%20over%20dipeptidyl%20peptidase-4%20inhibition%20mechanism%20and%20insulinotropic%20activities&amp;author=B.%20Bindu&amp;author=S.%20Vijayalakshmi&amp;author=A.%20Manikandan&amp;volume=187&amp;publication_year=2020&amp;pages=111912&amp;pmid=31812034&amp;doi=10.1016/j.ejmech.2019.111912&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>Jain A., Chaudhary J., Khaira H., Chopra B., Dhingra A.. Piperazine:
a promising scaffold with analgesic and anti-inflammatory potential. Drug Research. 2021;71(02):62–72. doi: 10.1055/a-1323-2813.</cite> [<a href="https://doi.org/10.1055/a-1323-2813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33336346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Research&amp;title=Piperazine:%20a%20promising%20scaffold%20with%20analgesic%20and%20anti-inflammatory%20potential&amp;author=A.%20Jain&amp;author=J.%20Chaudhary&amp;author=H.%20Khaira&amp;author=B.%20Chopra&amp;author=A.%20Dhingra&amp;volume=71&amp;issue=02&amp;publication_year=2021&amp;pages=62-72&amp;pmid=33336346&amp;doi=10.1055/a-1323-2813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Xiong J., Jin J., Gao L., Hao C., Liu X., Liu B.-F., Chen Y., Zhang G.. Piperidine propionamide as a scaffold
for potent sigma-1 receptor antagonists and mu opioid receptor agonists
for treating neuropathic pain. Eur. J. Med.
Chem. 2020;191:112144. doi: 10.1016/j.ejmech.2020.112144.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2020.112144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32087465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Piperidine%20propionamide%20as%20a%20scaffold%20for%20potent%20sigma-1%20receptor%20antagonists%20and%20mu%20opioid%20receptor%20agonists%20for%20treating%20neuropathic%20pain&amp;author=J.%20Xiong&amp;author=J.%20Jin&amp;author=L.%20Gao&amp;author=C.%20Hao&amp;author=X.%20Liu&amp;volume=191&amp;publication_year=2020&amp;pages=112144&amp;pmid=32087465&amp;doi=10.1016/j.ejmech.2020.112144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Partyka A., Chlon-Rzepa G., Wasik A., Jastrzebska-Wiesek M., Bucki A., Kolaczkowski M., Satala G., Bojarski A. J., Wesolowska A.. Antidepressant-
and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione
derivatives with diversified 5-HT(1)­A receptor functional profile. Bioorg. Med. Chem. 2015;23(1):212. doi: 10.1016/j.bmc.2014.11.008.</cite> [<a href="https://doi.org/10.1016/j.bmc.2014.11.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25435254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Antidepressant-%20and%20anxiolytic-like%20activity%20of%207-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione%20derivatives%20with%20diversified%205-HT(1)%C2%ADA%20receptor%20functional%20profile&amp;author=A.%20Partyka&amp;author=G.%20Chlon-Rzepa&amp;author=A.%20Wasik&amp;author=M.%20Jastrzebska-Wiesek&amp;author=A.%20Bucki&amp;volume=23&amp;issue=1&amp;publication_year=2015&amp;pages=212&amp;pmid=25435254&amp;doi=10.1016/j.bmc.2014.11.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Partyka A., Jastrzębska-Więsek M., Canale V., Zajdel P., Wesołowska A.. Anxiolytic-like
activity of PZ-1433, a novel arylsulfonamide
derivative of aryloxy (propyl) piperidine, in rodents. Medicina Internacia Revuo. 2018;28(110):35–46.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Medicina%20Internacia%20Revuo&amp;title=Anxiolytic-like%20activity%20of%20PZ-1433,%20a%20novel%20arylsulfonamide%20derivative%20of%20aryloxy%20(propyl)%20piperidine,%20in%20rodents&amp;author=A.%20Partyka&amp;author=M.%20Jastrze%CC%A8bska-Wie%CC%A8sek&amp;author=V.%20Canale&amp;author=P.%20Zajdel&amp;author=A.%20Weso%C5%82owska&amp;volume=28&amp;issue=110&amp;publication_year=2018&amp;pages=35-46&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Costanzo P., Cariati L., Desiderio D., Sgammato R., Lamberti A., Arcone R., Salerno R., Nardi M., Masullo M., Oliverio M.. Design, synthesis,
and evaluation of donepezil-like
compounds as AChE and BACE-1 inhibitors. ACS
Med. Chem. Lett. 2016;7(5):470–475. doi: 10.1021/acsmedchemlett.5b00483.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.5b00483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4867475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27190595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Design,%20synthesis,%20and%20evaluation%20of%20donepezil-like%20compounds%20as%20AChE%20and%20BACE-1%20inhibitors&amp;author=P.%20Costanzo&amp;author=L.%20Cariati&amp;author=D.%20Desiderio&amp;author=R.%20Sgammato&amp;author=A.%20Lamberti&amp;volume=7&amp;issue=5&amp;publication_year=2016&amp;pages=470-475&amp;pmid=27190595&amp;doi=10.1021/acsmedchemlett.5b00483&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Gabr M. T., Abdel-Raziq M. S.. Design
and synthesis of donepezil analogues as dual
AChE and BACE-1 inhibitors. Bioorg. Chem. 2018;80:245–252. doi: 10.1016/j.bioorg.2018.06.031.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2018.06.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29966870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Design%20and%20synthesis%20of%20donepezil%20analogues%20as%20dual%20AChE%20and%20BACE-1%20inhibitors&amp;author=M.%20T.%20Gabr&amp;author=M.%20S.%20Abdel-Raziq&amp;volume=80&amp;publication_year=2018&amp;pages=245-252&amp;pmid=29966870&amp;doi=10.1016/j.bioorg.2018.06.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Qin P., Ran Y., Xie F., Liu Y., Wei C., Luan X., Wu J.. Design, synthesis,
and biological evaluation of novel N-Benzyl piperidine
derivatives as potent HDAC/AChE inhibitors for Alzheimer’s
disease. Bioorg. Med. Chem. 2023;80:117178. doi: 10.1016/j.bmc.2023.117178.</cite> [<a href="https://doi.org/10.1016/j.bmc.2023.117178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36706609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.&amp;title=Design,%20synthesis,%20and%20biological%20evaluation%20of%20novel%20N-Benzyl%20piperidine%20derivatives%20as%20potent%20HDAC/AChE%20inhibitors%20for%20Alzheimer%E2%80%99s%20disease&amp;author=P.%20Qin&amp;author=Y.%20Ran&amp;author=F.%20Xie&amp;author=Y.%20Liu&amp;author=C.%20Wei&amp;volume=80&amp;publication_year=2023&amp;pages=117178&amp;pmid=36706609&amp;doi=10.1016/j.bmc.2023.117178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Kiran P. V. R., Waiker D. K., Verma A., Saraf P., Bhardwaj B., Kumar H., Singh A., Kumar P., Singh N., Srikrishna S.. et al. Design and development of benzyl piperazine
linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential
agents to combat Alzheimer’s disease. Bioorg. Chem. 2023;139:106749. doi: 10.1016/j.bioorg.2023.106749.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2023.106749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37517157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Design%20and%20development%20of%20benzyl%20piperazine%20linked%205-phenyl-1,%202,%204-triazole-3-thione%20conjugates%20as%20potential%20agents%20to%20combat%20Alzheimer%E2%80%99s%20disease&amp;author=P.%20V.%20R.%20Kiran&amp;author=D.%20K.%20Waiker&amp;author=A.%20Verma&amp;author=P.%20Saraf&amp;author=B.%20Bhardwaj&amp;volume=139&amp;publication_year=2023&amp;pages=106749&amp;pmid=37517157&amp;doi=10.1016/j.bioorg.2023.106749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Waiker D. K., Verma A., Akhilesh, Singh N., Singh N., Roy A., Dilnashin H., Tiwari V., Trigun S. K., Singh S. P.. et al. Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine
Hybrids of 5-Phenyl-1, 3, 4-oxadiazol-2-thiol as Potential Multitargeted
Ligands for Alzheimer’s Disease Therapy. ACS Chem. Neurosci. 2023;14:2217–2242. doi: 10.1021/acschemneuro.3c00245.</cite> [<a href="https://doi.org/10.1021/acschemneuro.3c00245" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37216500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem.%20Neurosci.&amp;title=Design,%20Synthesis,%20and%20Biological%20Evaluation%20of%20Piperazine%20and%20N-Benzylpiperidine%20Hybrids%20of%205-Phenyl-1,%203,%204-oxadiazol-2-thiol%20as%20Potential%20Multitargeted%20Ligands%20for%20Alzheimer%E2%80%99s%20Disease%20Therapy&amp;author=D.%20K.%20Waiker&amp;author=A.%20Verma&amp;author=%20Akhilesh&amp;author=N.%20Singh&amp;author=N.%20Singh&amp;volume=14&amp;publication_year=2023&amp;pages=2217-2242&amp;pmid=37216500&amp;doi=10.1021/acschemneuro.3c00245&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Sharma P., Tripathi A., Tripathi P. N., Prajapati S. K., Seth A., Tripathi M. K., Srivastava P., Tiwari V., Krishnamurthy S., Shrivastava S. K.. Design
and development of multitarget-directed N-Benzylpiperidine analogs
as potential candidates for the treatment of Alzheimer’s disease. Eur. J. Med. Chem. 2019;167:510–524. doi: 10.1016/j.ejmech.2019.02.030.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.02.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30784883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Design%20and%20development%20of%20multitarget-directed%20N-Benzylpiperidine%20analogs%20as%20potential%20candidates%20for%20the%20treatment%20of%20Alzheimer%E2%80%99s%20disease&amp;author=P.%20Sharma&amp;author=A.%20Tripathi&amp;author=P.%20N.%20Tripathi&amp;author=S.%20K.%20Prajapati&amp;author=A.%20Seth&amp;volume=167&amp;publication_year=2019&amp;pages=510-524&amp;pmid=30784883&amp;doi=10.1016/j.ejmech.2019.02.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>Bajad N. G., Singh R. B., Gajendra T., Gutti G., Kumar A., Krishnamurthy S., Singh S. K.. Development of multi-targetable chalcone
derivatives bearing N-aryl piperazine moiety for the treatment of
Alzheimer’s disease. Bioorg. Chem. 2024;143:107082. doi: 10.1016/j.bioorg.2023.107082.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2023.107082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38199142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Development%20of%20multi-targetable%20chalcone%20derivatives%20bearing%20N-aryl%20piperazine%20moiety%20for%20the%20treatment%20of%20Alzheimer%E2%80%99s%20disease&amp;author=N.%20G.%20Bajad&amp;author=R.%20B.%20Singh&amp;author=T.%20Gajendra&amp;author=G.%20Gutti&amp;author=A.%20Kumar&amp;volume=143&amp;publication_year=2024&amp;pages=107082&amp;pmid=38199142&amp;doi=10.1016/j.bioorg.2023.107082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>Mezeiova E., Chalupova K., Nepovimova E., Gorecki L., Prchal L., Malinak D., Kuca K., Soukup O., Korabecny J.. Donepezil
derivatives targeting amyloid-β cascade in Alzheimer’s
disease. Curr. Alzheimer Res. 2019;16(9):772–800. doi: 10.2174/1567205016666190228122956.</cite> [<a href="https://doi.org/10.2174/1567205016666190228122956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30819078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Alzheimer%20Res.&amp;title=Donepezil%20derivatives%20targeting%20amyloid-%CE%B2%20cascade%20in%20Alzheimer%E2%80%99s%20disease&amp;author=E.%20Mezeiova&amp;author=K.%20Chalupova&amp;author=E.%20Nepovimova&amp;author=L.%20Gorecki&amp;author=L.%20Prchal&amp;volume=16&amp;issue=9&amp;publication_year=2019&amp;pages=772-800&amp;pmid=30819078&amp;doi=10.2174/1567205016666190228122956&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Pathak C., Kabra U. D.. A comprehensive
review of multi-target directed ligands
in the treatment of Alzheimer’s disease. Bioorg. Chem. 2024;144:107152. doi: 10.1016/j.bioorg.2024.107152.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2024.107152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38290187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=A%20comprehensive%20review%20of%20multi-target%20directed%20ligands%20in%20the%20treatment%20of%20Alzheimer%E2%80%99s%20disease&amp;author=C.%20Pathak&amp;author=U.%20D.%20Kabra&amp;volume=144&amp;publication_year=2024&amp;pages=107152&amp;pmid=38290187&amp;doi=10.1016/j.bioorg.2024.107152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Mathew B., Oh J. M., Baty R. S., Batiha G. E.-S., Parambi D. G. T., Gambacorta N., Nicolotti O., Kim H.. Piperazine-substituted
chalcones: A new class of MAO-B, AChE, and BACE-1 inhibitors for the
treatment of neurological disorders. Environ.
Sci. Pollut. Res. 2021;28:38855–38866. doi: 10.1007/s11356-021-13320-y.</cite> [<a href="https://doi.org/10.1007/s11356-021-13320-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7980107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33743158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ.%20Sci.%20Pollut.%20Res.&amp;title=Piperazine-substituted%20chalcones:%20A%20new%20class%20of%20MAO-B,%20AChE,%20and%20BACE-1%20inhibitors%20for%20the%20treatment%20of%20neurological%20disorders&amp;author=B.%20Mathew&amp;author=J.%20M.%20Oh&amp;author=R.%20S.%20Baty&amp;author=G.%20E.-S.%20Batiha&amp;author=D.%20G.%20T.%20Parambi&amp;volume=28&amp;publication_year=2021&amp;pages=38855-38866&amp;pmid=33743158&amp;doi=10.1007/s11356-021-13320-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Yurttaş L., Evren A. E., AlChaib H., Temel H. E., Akalin
Çiftçi G.. Synthesis, molecular docking, and molecular dynamic
simulation studies of new 1,3,4-thiadiazole derivatives as potential
apoptosis inducers in A549 lung cancer cell line. J. Biomol. Struct. Dyn. 2024;43:3814–3829. doi: 10.1080/07391102.2023.2300125.</cite> [<a href="https://doi.org/10.1080/07391102.2023.2300125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38166545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomol.%20Struct.%20Dyn.&amp;title=Synthesis,%20molecular%20docking,%20and%20molecular%20dynamic%20simulation%20studies%20of%20new%201,3,4-thiadiazole%20derivatives%20as%20potential%20apoptosis%20inducers%20in%20A549%20lung%20cancer%20cell%20line&amp;author=L.%20Yurtta%C5%9F&amp;author=A.%20E.%20Evren&amp;author=H.%20AlChaib&amp;author=H.%20E.%20Temel&amp;author=G.%20Akalin%20%C3%87ift%C3%A7i&amp;volume=43&amp;publication_year=2024&amp;pages=3814-3829&amp;pmid=38166545&amp;doi=10.1080/07391102.2023.2300125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Yucel N. T., Asfour A. A. R., Evren A. E., Yazici C., Kandemir U., Ozkay U. D., Can O. D., Yurttas L.. Design and synthesis
of novel dithiazole carboxylic acid Derivatives: In vivo and in silico
investigation of their Anti-Inflammatory and analgesic effects. Bioorg. Chem. 2024;144:107120. doi: 10.1016/j.bioorg.2024.107120.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2024.107120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38219479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Design%20and%20synthesis%20of%20novel%20dithiazole%20carboxylic%20acid%20Derivatives:%20In%20vivo%20and%20in%20silico%20investigation%20of%20their%20Anti-Inflammatory%20and%20analgesic%20effects&amp;author=N.%20T.%20Yucel&amp;author=A.%20A.%20R.%20Asfour&amp;author=A.%20E.%20Evren&amp;author=C.%20Yazici&amp;author=U.%20Kandemir&amp;volume=144&amp;publication_year=2024&amp;pages=107120&amp;pmid=38219479&amp;doi=10.1016/j.bioorg.2024.107120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Evren A. E., Karaduman A. B., Saglik B. N., Ozkay Y., Yurttas L.. Investigation
of Novel Quinoline-Thiazole Derivatives as Antimicrobial Agents: In
Vitro and In Silico Approaches. ACS Omega. 2023;8(1):1410–1429. doi: 10.1021/acsomega.2c06871.</cite> [<a href="https://doi.org/10.1021/acsomega.2c06871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9835529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36643421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Investigation%20of%20Novel%20Quinoline-Thiazole%20Derivatives%20as%20Antimicrobial%20Agents:%20In%20Vitro%20and%20In%20Silico%20Approaches&amp;author=A.%20E.%20Evren&amp;author=A.%20B.%20Karaduman&amp;author=B.%20N.%20Saglik&amp;author=Y.%20Ozkay&amp;author=L.%20Yurttas&amp;volume=8&amp;issue=1&amp;publication_year=2023&amp;pages=1410-1429&amp;pmid=36643421&amp;doi=10.1021/acsomega.2c06871&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref44">
<cite>Dawbaa S., Nuha D., Evren A. E., Cankiliç M. Y., Yurttaş L., Turan G.. New oxadiazole/triazole
derivatives
with antimicrobial and antioxidant properties. J. Mol. Struct. 2023;1282:135213. doi: 10.1016/j.molstruc.2023.135213.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2023.135213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=New%20oxadiazole/triazole%20derivatives%20with%20antimicrobial%20and%20antioxidant%20properties&amp;author=S.%20Dawbaa&amp;author=D.%20Nuha&amp;author=A.%20E.%20Evren&amp;author=M.%20Y.%20Cankili%C3%A7&amp;author=L.%20Yurtta%C5%9F&amp;volume=1282&amp;publication_year=2023&amp;pages=135213&amp;doi=10.1016/j.molstruc.2023.135213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45">
<cite>Daina A., Zoete V.. A BOILED-Egg To Predict
Gastrointestinal Absorption and Brain Penetration
of Small Molecules. ChemMedChem. 2016;11(11):1117. doi: 10.1002/cmdc.201600182.</cite> [<a href="https://doi.org/10.1002/cmdc.201600182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5089604/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27218427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=A%20BOILED-Egg%20To%20Predict%20Gastrointestinal%20Absorption%20and%20Brain%20Penetration%20of%20Small%20Molecules&amp;author=A.%20Daina&amp;author=V.%20Zoete&amp;volume=11&amp;issue=11&amp;publication_year=2016&amp;pages=1117&amp;pmid=27218427&amp;doi=10.1002/cmdc.201600182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref46">
<cite>Nehra G., Bauer B., Hartz A. M. S.. Blood-brain barrier leakage in Alzheimer’s
disease: From discovery to clinical relevance. Pharmacol. Ther. 2022;234:108119. doi: 10.1016/j.pharmthera.2022.108119.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2022.108119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9107516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35108575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Ther.&amp;title=Blood-brain%20barrier%20leakage%20in%20Alzheimer%E2%80%99s%20disease:%20From%20discovery%20to%20clinical%20relevance&amp;author=G.%20Nehra&amp;author=B.%20Bauer&amp;author=A.%20M.%20S.%20Hartz&amp;volume=234&amp;publication_year=2022&amp;pages=108119&amp;pmid=35108575&amp;doi=10.1016/j.pharmthera.2022.108119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Ellman G. L., Courtney K. D., Andres V. Jr., Feather-Stone R. M.. A new and
rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7(2):88–95. doi: 10.1016/0006-2952(61)90145-9.</cite> [<a href="https://doi.org/10.1016/0006-2952(61)90145-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13726518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Pharmacol.&amp;title=A%20new%20and%20rapid%20colorimetric%20determination%20of%20acetylcholinesterase%20activity&amp;author=G.%20L.%20Ellman&amp;author=K.%20D.%20Courtney&amp;author=V.%20Andres&amp;author=R.%20M.%20Feather-Stone&amp;volume=7&amp;issue=2&amp;publication_year=1961&amp;pages=88-95&amp;pmid=13726518&amp;doi=10.1016/0006-2952(61)90145-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Osmaniye D., Evren A. E., Sağlık B.
N., Levent S., Ozkay Y., Kaplancıklı Z. A.. Design, synthesis,
biological activity, molecular docking, and molecular dynamics of
novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors. Arch. Pharm. (Weinheim, Ger.) 2022;355(3):2100450. doi: 10.1002/ardp.202100450.</cite> [<a href="https://doi.org/10.1002/ardp.202100450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34931332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Pharm.%20(Weinheim,%20Ger.)&amp;title=Design,%20synthesis,%20biological%20activity,%20molecular%20docking,%20and%20molecular%20dynamics%20of%20novel%20benzimidazole%20derivatives%20as%20potential%20AChE/MAO-B%20dual%20inhibitors&amp;author=D.%20Osmaniye&amp;author=A.%20E.%20Evren&amp;author=B.%20N.%20Sa%C4%9Fl%C4%B1k&amp;author=S.%20Levent&amp;author=Y.%20Ozkay&amp;volume=355&amp;issue=3&amp;publication_year=2022&amp;pages=2100450&amp;pmid=34931332&amp;doi=10.1002/ardp.202100450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Durmaz Ş., Evren A. E., Sağlık B.
N., Yurttaş L., Tay N. F.. Synthesis, anticholinesterase activity, molecular docking,
and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives. Arch. Pharm. (Weinheim, Ger.) 2022;355(11):2200294. doi: 10.1002/ardp.202200294.</cite> [<a href="https://doi.org/10.1002/ardp.202200294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35972839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Pharm.%20(Weinheim,%20Ger.)&amp;title=Synthesis,%20anticholinesterase%20activity,%20molecular%20docking,%20and%20molecular%20dynamic%20simulation%20studies%20of%201,3,4-oxadiazole%20derivatives&amp;author=%C5%9E.%20Durmaz&amp;author=A.%20E.%20Evren&amp;author=B.%20N.%20Sa%C4%9Fl%C4%B1k&amp;author=L.%20Yurtta%C5%9F&amp;author=N.%20F.%20Tay&amp;volume=355&amp;issue=11&amp;publication_year=2022&amp;pages=2200294&amp;pmid=35972839&amp;doi=10.1002/ardp.202200294&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>Tok F., Sağlık B. N., Özkay Y., Kaplancıklı Z. A., Koçyiğit-Kaymakçıoğlu B.. Design, synthesis,
biological activity evaluation and in silico studies of new nicotinohydrazide
derivatives as multi-targeted inhibitors for Alzheimer’s disease. J. Mol. Struct. 2022;1265:133441. doi: 10.1016/j.molstruc.2022.133441.</cite> [<a href="https://doi.org/10.1016/j.molstruc.2022.133441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Design,%20synthesis,%20biological%20activity%20evaluation%20and%20in%20silico%20studies%20of%20new%20nicotinohydrazide%20derivatives%20as%20multi-targeted%20inhibitors%20for%20Alzheimer%E2%80%99s%20disease&amp;author=F.%20Tok&amp;author=B.%20N.%20Sa%C4%9Fl%C4%B1k&amp;author=Y.%20%C3%96zkay&amp;author=Z.%20A.%20Kaplanc%C4%B1kl%C4%B1&amp;author=B.%20Ko%C3%A7yi%C4%9Fit-Kaymak%C3%A7%C4%B1o%C4%9Flu&amp;volume=1265&amp;publication_year=2022&amp;pages=133441&amp;doi=10.1016/j.molstruc.2022.133441&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>Saglik B. N., Ilgin S., Ozkay Y.. Synthesis
of new donepezil analogues
and investigation of their effects on cholinesterase enzymes. Eur. J. Med. Chem. 2016;124:1026–1040. doi: 10.1016/j.ejmech.2016.10.042.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2016.10.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27783974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20of%20new%20donepezil%20analogues%20and%20investigation%20of%20their%20effects%20on%20cholinesterase%20enzymes&amp;author=B.%20N.%20Saglik&amp;author=S.%20Ilgin&amp;author=Y.%20Ozkay&amp;volume=124&amp;publication_year=2016&amp;pages=1026-1040&amp;pmid=27783974&amp;doi=10.1016/j.ejmech.2016.10.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Demir
Ozkay U., Can O. D., Saglik B. N., Acar
Cevik U., Levent S., Ozkay Y., Ilgin S., Atli O.. Design, synthesis, and AChE inhibitory activity of new benzothiazole-piperazines. Bioorg. Med. Chem. Lett. 2016;26(22):5387–5394. doi: 10.1016/j.bmcl.2016.10.041.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2016.10.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27789142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Design,%20synthesis,%20and%20AChE%20inhibitory%20activity%20of%20new%20benzothiazole-piperazines&amp;author=U.%20Demir%20Ozkay&amp;author=O.%20D.%20Can&amp;author=B.%20N.%20Saglik&amp;author=U.%20Acar%20Cevik&amp;author=S.%20Levent&amp;volume=26&amp;issue=22&amp;publication_year=2016&amp;pages=5387-5394&amp;pmid=27789142&amp;doi=10.1016/j.bmcl.2016.10.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Tok F., Koçyigit-Kaymakçioglu B., Saglik B. N., Levent S., Özkay Y., Kaplancikli Z. A.. Synthesis and biological evaluation
of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase
inhibitors. Bioorg. Chem. 2019;84:41–50. doi: 10.1016/j.bioorg.2018.11.016.</cite> [<a href="https://doi.org/10.1016/j.bioorg.2018.11.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30481645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Chem.&amp;title=Synthesis%20and%20biological%20evaluation%20of%20new%20pyrazolone%20Schiff%20bases%20as%20monoamine%20oxidase%20and%20cholinesterase%20inhibitors&amp;author=F.%20Tok&amp;author=B.%20Ko%C3%A7yigit-Kaymak%C3%A7ioglu&amp;author=B.%20N.%20Saglik&amp;author=S.%20Levent&amp;author=Y.%20%C3%96zkay&amp;volume=84&amp;publication_year=2019&amp;pages=41-50&amp;pmid=30481645&amp;doi=10.1016/j.bioorg.2018.11.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>Al-Sharabi A. A., Evren A. E., Saglik B. N., Yurttas L.. Synthesis,
characterization,
molecular docking and molecular dynamics simulations of novel 2,5-disubstituted-1,3,4-thiadiazole
derivatives as potential cholinesterase/monoamine oxidase dual inhibitors
for Alzheimer’s disease. J. Biomol. Struct.
Dyn. 2023;42:13023. doi: 10.1080/07391102.2023.2274967.</cite> [<a href="https://doi.org/10.1080/07391102.2023.2274967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37909464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biomol.%20Struct.%20Dyn.&amp;title=Synthesis,%20characterization,%20molecular%20docking%20and%20molecular%20dynamics%20simulations%20of%20novel%202,5-disubstituted-1,3,4-thiadiazole%20derivatives%20as%20potential%20cholinesterase/monoamine%20oxidase%20dual%20inhibitors%20for%20Alzheimer%E2%80%99s%20disease&amp;author=A.%20A.%20Al-Sharabi&amp;author=A.%20E.%20Evren&amp;author=B.%20N.%20Saglik&amp;author=L.%20Yurttas&amp;volume=42&amp;publication_year=2023&amp;pages=13023&amp;pmid=37909464&amp;doi=10.1080/07391102.2023.2274967&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>Naji S. A., Sağlik B. N., Agamennone M., Evren A. E., Gundogdu-Karaburun N., Karaburun A. C. ¸.. Design and Evaluation of Synthesized
Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR
Approach. ACS Omega. 2023;8:48884. doi: 10.1021/acsomega.3c06344.</cite> [<a href="https://doi.org/10.1021/acsomega.3c06344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10753557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38162789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Design%20and%20Evaluation%20of%20Synthesized%20Pyrrole%20Derivatives%20as%20Dual%20COX-1%20and%20COX-2%20Inhibitors%20Using%20FB-QSAR%20Approach&amp;author=S.%20A.%20Naji&amp;author=B.%20N.%20Sa%C4%9Flik&amp;author=M.%20Agamennone&amp;author=A.%20E.%20Evren&amp;author=N.%20Gundogdu-Karaburun&amp;volume=8&amp;publication_year=2023&amp;pages=48884&amp;pmid=38162789&amp;doi=10.1021/acsomega.3c06344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>Yurttaş L., Evren A. E., Kubilay A., Aksoy M. O., Temel H. E., Akalın Çiftçi G.. Synthesis of Some New 1,3,4-Oxadiazole
Derivatives and Evaluation of Their Anticancer Activity. ACS Omega. 2023;8:49311. doi: 10.1021/acsomega.3c07776.</cite> [<a href="https://doi.org/10.1021/acsomega.3c07776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10753699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38162760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Synthesis%20of%20Some%20New%201,3,4-Oxadiazole%20Derivatives%20and%20Evaluation%20of%20Their%20Anticancer%20Activity&amp;author=L.%20Yurtta%C5%9F&amp;author=A.%20E.%20Evren&amp;author=A.%20Kubilay&amp;author=M.%20O.%20Aksoy&amp;author=H.%20E.%20Temel&amp;volume=8&amp;publication_year=2023&amp;pages=49311&amp;pmid=38162760&amp;doi=10.1021/acsomega.3c07776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Evren A. E., Nuha D., Dawbaa S., Saglik B. N., Yurttas L.. Synthesis
of novel thiazolyl hydrazone derivatives as potent dual monoamine
oxidase-aromatase inhibitors. Eur. J. Med. Chem. 2022;229:114097. doi: 10.1016/j.ejmech.2021.114097.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2021.114097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34998057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Synthesis%20of%20novel%20thiazolyl%20hydrazone%20derivatives%20as%20potent%20dual%20monoamine%20oxidase-aromatase%20inhibitors&amp;author=A.%20E.%20Evren&amp;author=D.%20Nuha&amp;author=S.%20Dawbaa&amp;author=B.%20N.%20Saglik&amp;author=L.%20Yurttas&amp;volume=229&amp;publication_year=2022&amp;pages=114097&amp;pmid=34998057&amp;doi=10.1016/j.ejmech.2021.114097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12332554/bin/ao5c01432_si_001.pdf" data-ga-action="click_feat_suppl" class="usa-link">ao5c01432_si_001.pdf</a><sup> (2.2MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Omega are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsomega.5c01432"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ao5c01432.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332554/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332554/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332554%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332554/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332554/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332554/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40787376/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332554/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40787376/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332554/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332554/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="c20U9lypbtRvUZTNgn1E7PvLiwgjjRY0FLbosrjXV2J3v4O1Xg8Bkwel5SNNmdJz">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
